Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 10, 1986 - Issue 3
4
Views
11
CrossRef citations to date
0
Altmetric
Miscellaneous Article

International Hemoglobin Information Center IHIC Variants List

Pages 261-327 | Published online: 07 Jul 2009

References

  • Crookston J. H., Beale D., Irvine D., Lehmann H. A new Haemoglobin J Toronto (α5 Alanine Aspartic acid). Nature 1965; 208: 1059–1061
  • Sumida I., Ohta Y., Imamura T., Yanase T. Hemoglobin Sawara: α6(A4) Aspartic acidAlanine. Biochim. Biophys. Acta 1973; 322: 23–26
  • Sasaki J., Imamura T., Sumida I., Yanase T., Ohya M. Increased oxygen affinity for Hemoglobin Sawara: βA4(6) Aspartic acidAlanine. Biochim. Biophys. Acta 1977; 495: 183–186
  • Jun D. L., Johnson M. H., Patchen L. C., Moo-Penn W. F. Hemoglobin Dunn: α6(A4) Aspartic acidAsparagine. Hemoglobin 1979; 3: 137–143
  • Pootrakul S., Kematorn B., Na-Nakorn S., Suanpan S. A new hemoglobin variant: Haemoglobin Anantharaj alpha 11 (A9) LysineGlutamic acid. Biochim. Biophys. Acta 1975; 405: 161–166
  • Rosa J., Maleknia N., Vergoz D., Dunet R. Une nouvelle hemoglobine anormale: l'hémoglobin J α Paris 12 AlaAsp. Nouv. Rev. Fr. D'Hemat. 1965; 6: 423–426
  • Trincao C., Martins De Melo J., Lorkin P. A., Lehmann H. Haemoglobin J Paris in the South of Portugal (Algarve). Acta Haematol. 1968; 39: 291–298
  • Marti H. R., Pik C., Mosimann P. Eine neue hämoglobin I variante: Hb I Interlaken. Acta Haematol. 1964; 32: 9–16
  • Liddell J., Brown D., Beale D., Lehmann H., Huntsman R. G. A new haemoglobin - Jα Oxford found during a survey of an English population. Nature 1964; 204: 269–270
  • Silvestroni E., Blanco I., Tentori L., Vivaldi G., Carta S., Sorcini M., Brancati C. (1967) Proc. 10th Congr. Eur. Soc. Hematol., Strasbourg, 1965. Karger, Basel/New York, 232–237, Part II
  • Vella F., Casey R., Lehmann H., Labossiere A., Jones T. G. Haemoglobin Ottawa: α2 15(A13) GlyArg β2. Biochim. Biophys. Acta 1974; 336: 25–29
  • Pootrakul S., Srichiyanont S., Wasi P., Suanpan S. Hemoglobin Siam (α2 15 Arg β2): A new a chain variant. Humangenetik 1974; 23: 199–204
  • Beale D., Lehmann H. Abnormal haemoglobin and the genetic code. Nature 1965; 207: 259–261
  • Schneider R. G., Alperin J. B., Beale D., Lehmann H. Hemoglobin I in an American Negro family: Structural and hematologic studies. J. Lab. Clin. Med. 1966; 68: 940–946
  • Bowman B. H., Barnett D. R. Amino-acid substitution in Haemoglobin I (Texas variant). Nature 1967; 214: 499
  • O'Brien C., Gray M. J., Jacobs A. S. A survey of cord blood for abnormal hemoglobin with further observations on Hemoglobin I Burlington. Am. J. Obstet. Gynecol. 1964; 88: 816–822
  • Baur E. W. Hb α2 glu β2 (Hb I) in a Caucasian family: Independent mutation or common origin?. Humangenetik 1968; 6: 368–372
  • Griffiths K. D., Lang A., Lehmann H., Mann J. R., Plowman D., Raine D. N. Haemoglobin Handsworth α18 (A16) GlycineArginine. FEBS Lett. 1977; 75: 93–95
  • Rahbar S., Ala F., Akhavan E., Nowzari G., Shoa'i I., Zamanianpoor M. H. Two new haemoglobins: Haemoglobin Perspolis [α64 (E13) AspTyr] and Haemoglobin J-Kurosh [α19 (AB1) AlaAsp]. Biochim. Biophys. Acta 1976; 427: 119–125
  • Kendall A. G., Barr R. D., Lang A., Lehmann H. Haemoglobin J Nyanza: α21 (B2) AlaAsp. Biochim. Biophys. Acta 1973; 310: 357–359
  • Gottlieb A. J., Restrepo A., Itano H. A. Hemoglobin J Medellin. Chemical and genetic study. Fed. Proc. 1964; 23: 172
  • Kraus A. P., Miyaji T., Luchi I., Kraus L. M. Memphis. A new variety of sickle cell anemia with clinically mild symptoms due to an α-chain variant of hemoglobin (α23 Glu NH2). J. Lab. Clin. Med. 1965; 66: 886–887
  • Boyer S. H., Crosby E. F., Fuller G. F., Ulenurm L., Buck A. A. A survey of hemoglobins in the Republic of Chad and characterization of Hemoglobin Chad. α2 23GluLys β2. Am. J. Hum. Genet. 1968; 20: 570–578
  • Marengo-Rowe A. J., Beale D., Lehmann H. New human haemoglobin variant from southern Arabia: C-Audhall (α23 (B4) Glutamic acidValine) and the variability of B4 in human haemoglobin. Nature 1968; 219: 1164–1166
  • Schneider R. G., Brimhall B., Jones R. T., Bryant R., Mitchell C. B., Goldberg A. I. Hb Fort Worth: α27 GluGly (B8) a variant present in unusually low concentration. Biochim. Biophys. Acta 1971; 243: 164–169
  • Ahern E., Ahern V., Holder W., Palomino E., Serjeant G. R., Serjeant B. E., Forbes M., Brimhall B., Jones R. T. Haemoglobin Spanish Town α27 GluVal (B8). Biochim. Biophys. Acta 1976; 427: 530–538
  • Vettore L., DeSandre G., Dilorio E. E., Winterhalter K. H., Lang A., Lehmann H. A new abnormal hemoglobin O Padova, α30 (B11) GluLys and a dyserythropoietic anemia with erythroblastic multinuclearity co-existing in the same patient. Blood 1974; 44: 869–877
  • Schneider R. G., Jim R. T. S. A new haemoglobin variant (the ‘Honolulu Type’) in a Chinese. Nature 1961; 190: 454–455
  • Vella F., Agar J. A. M., Lehmann H. An abnormal haemoglobin in a Chinese: Haemoglobin G. Nature 1958; 182: 460–461
  • Swenson R. T., Hill R. L., Lehmann H., Jim R. T. S. A chemical abnormality in Hemoglobin G from Chinese individuals. J. Biol. Chem. 1962; 237: 1517–1520
  • Marinucci M., Mavilio F., Tentori L., D'Erasmo F., Colapietro A., De Stasio G., Di Fonzo S. A new human hemoglobin variant: Hb Bari (a2 45(CD3) HisGln β2). Biochim. Biophys. Acta 1980; 622: 315–319
  • Beretta A., Prato V., Gallo E., Lehmann H. Haemoglobin Torino - α43 (CD1) PhenylalanineValine. Nature 1968; 217: 1016–1018
  • Ohba Y., Miyaji T., Matsouka M., Yokoyama M., Numakura H., Nagata K., Takebe Y., Izumi Y., Shibata S. Hemoglobin Hirosaki (α43 [CE1] PheLeu), a new unstable variant. Biochim. Biophys. Acta 1975; 405: 155–160
  • Braconnier F., Gacon G., Thillet J., Wajcman H., Soria J., Maigret P., Labie D., Rosa J. Hemoglobin Fort de France (α24s (CD3) HisArg β2) a new variant with increased oxygen affinity. Biochim. Biophys. Acta 1977; 493: 228–233
  • Sumida I. Studies of abnormal hemoglobins in Western Japan. Frequency of visible hemoglobin variants, and chemical characterization of Hemoglobin Sawara (α2 6Ala β2) and Hemoglobin Mugina (Hb L Ferrara; α2 47Gly β2). Jap. J. Hum. Genet. 1975; 19: 343–363
  • Fujimura T., Kawasaki K., Imamura T., Ohta Y., Hanada M., Yamaoka K. Two kindreds of abnormal hemoglobins: Hb Tagawa I and Hb Tagawa II. Jap. J. Clin. Hematol. 1964; 6: 71
  • DeVries A., Joshua H., Lehmann H., Hill R. L., Fellows R. E. The first observation of an abnormal haemoglobin in a Jewish family: Haemoglobin Beilinson. Br. J. Haematol. 1963; 9: 484–486
  • Halbrecht I., Isaacs W. A., Lehmann H., Ben-Porat F. Hemoglobin Hasharon (α17 Aspartic acidHistidine). Israel J. Med. Sci. 1967; 3: 827–831
  • Ostertag W., Smith E. W. Hb Sinai: A new a chain mutant α47 His. Humangenetik 1968; 6: 377–379
  • Schneider R. G., Ueda S., Alperin J. B., Brimhall B., Jones R. T. Hemoglobin Sealy (α2 47His β2): A new variant in a Jewish family. Am. J. Hum. Genet. 1968; 20: 151–156
  • Bianco I., Modiano G., Bottini E., Lucci R. Alteration in the α-chain of Haemoglobin L Ferrara. Nature 1963; 198: 395–396
  • Tentori L. Hemoglobin L Ferrara = Hemoglobin Hasharon. Hemoglobin 1977; 1: 602
  • Rahbar S., Mahdavi N., Nowzari G., Mostafavi I. Hemoglobin Arya: α2 47(CD5) Aspartic acidAsparagine. Biochim. Biophys. Acta 1975; 386: 525–529
  • Brimhall S., Jones R. T., Schneider R. G., Hosty T. S., Tomlin G., Atkins R. Two new hemoglobins: Hemoglobin Alabama (β39 (C5) GlnLys) and Hemoglobin Montgomery (α48 (CD6) LeuArg). Biochim. Biophys. Acta 1975; 379: 28–32
  • Tangheroni W., Zorcolo G., Gallo E., Lehmann H. Haemoglobin J Sardegna: α50 (CD8) HistidineAspartic acid. Nature 1968; 218: 470–471
  • Cabannes R., Renaud R., Mauran A., Pennors H., Charlesworth D., Price B. G., Lehmann H. Deux hemoglobines rapides an Cote-D'Ivoire: l'Hb K Woolwich et une nouvelle hemoglobin, l'Hb J Abidjan (α51 GlyAsp). Nouv. Rev. Fr. D'Hemat. 1972; 12: 289–300
  • Reynolds C. A., Huisman T. H. J. Hemoglobin Russ or α2 51 Arg β2. Biochim. Biophys. Acta 1966; 130: 541–543
  • Alberti R., Mariuzzi G. M., Artibani L., Bruni E., Tentori L. A new haemoglobin variant: J-Rovigo alpha 53 (E-2) AlanineAspartic acid. Biochim. Biophys. Acta 1974; 342: 1–4
  • Miyaji T., Luchi I., Takeda I., Shibata S. Hemoglobin Shimonoseki (α2 54Arg β2A), a slow-moving hemoglobin found in a Japanese family, with special reference to its chemistry. Acta Haematol. Jap. 1963; 26: 531–536
  • Jones R. T., Brimhall B., Lisker R. Chemical characterization of Hemoglobin Mexico and Hemoglobin Chiapas. Biochim. Biophys. Acta 1968; 154: 488–495
  • Rosa J., Labie D., Maleknia N., Blum N. Sur quelques hemoglobines anormales nouvelles recemment isolees en France. International Symposium on Comparative Hemoglobin Structure, Thessaloniki, April, 11–131966, 140–145
  • Fessas Ph., Kaltsoya A., Loukopoulos D., Nilsson L.-O. On the chemical structure of Haemoglobin Uppsala. Hum. Hered. 1969; 19: 152–158
  • Pootrakul S., Boonyarat D., Kematorn B., Suanpan S., Wasi P. Hemoglobin Thailand [α56 (E5) LysThr]: A new abnormal human hemoglobin. Hemoglobin 1977; 1: 781–798
  • Rahbar S., Kinderlerer J. L., Lehmann H. Haemoglobin L Persian Gulf: α57 (E6) GlycineArginine. Acta Haematol. 1969; 42: 169–175
  • Baglioni C. A chemical study of Hemoglobin Norfolk. J. Biol. Chem. 1962; 237: 69–74
  • Imamura T. Hemoglobin Kagoshima: An example of Hemoglobin Norfolk in a Japanese family. Am. J. Hum. Genet. 1966; 18: 584–593
  • Yanase T., Hanada M., Seita M., Ohya I., Ohta Y., Imamura T., Fujimura T., Kawasaki K., Yamaoka K. Molecular basis of morbidity - From a series of studies of hemoglobinopathies in Western Japan. Jap. J. Hum. Genet. 1968; 13: 40–53
  • Gerald P. S., Efron M. L. Chemical studies of several varieties of Hb M. Proc. Natl. Acad. Sci. USA 1961; 47: 1758–1767
  • Shimizu A., Hayashi A., Yamamura Y., Tsugita A., Kitayama K. The structural study on a new hemoglobin variant, Hb M Osaka. Biochim. Biophys. Acta 1965; 97: 472–482
  • Hansen H. A., Jagenburg O. R., Johansson B. G. Studies on an abnormal hemoglobin causing hereditary congenital cyanosis. Acta Paediatr. 1960; 119: 503–511
  • Hollan S. R., Szelenyi J. G., Lehmann H., Beale D. A Boston-type Haemoglobin M in Hungary: Haemoglobin M Kiskunhalas. Haematologia 1967; 1: 11–18
  • Barclay G. P. T., Charlesworth D., Lehmann H. Abnormal haemoglobin in Zambia. A new Haemoglobin Zambia α60 (E9) LysineAsparagine. Br. Med. J. 1969; 4: 595–596
  • Brimhall B., Duerst M., Hollan S. R., Stenzel P., Szelenyi J., Jones R. T. Structural characterizations of Hemoglobins J Buda (α61 (E10) LysAsn) and G Pest (α74 (EF3) AspAsn). Biochim. Biophys. Acta 1974; 336: 344–360
  • Thillet J., Blouquit Y., Perrone F., Rosa J. Hemoglobin Pontoise α63 AlaAsp (E12). A new fast moving variant. Biochim. Biophys. Acta 1977; 491: 16–22
  • Blackwell R. Q., Jim R. T. S., Tan T. G. H., Wang M.-I., Liu C.-S., Wang C.-L. Hemoglobin G Waimanalo: α64 AspAsn. Biochim. Biophys. Acta 1973; 322: 27–33
  • Ramot B., Kinderlerer J. B., Lehmann H. Geneva 1972, Cited in WHO Technical Report Series No. 509, Annex 1
  • Sukumaran P. K., Merchant S. M., Desai M. P., Wiltshire B. G., Lehmann H. Haemoglobin Q India (α64(E13) Aspartic acidHistidine) associated with β-thalassemia observed in three Sindhi families. J. Med. Genet. 1972; 9: 436–442
  • Miyaji T., Iuchi I., Yamamoto K., Ohba Y., Shibata S. Amino acid substitution of Hemoglobin Ube 2 (α2 68 Asp 62): An example of successful application of partial hydrolysis of peptide with 5% acetic acid. Clin. Chim. Acta 1967; 16: 347–352
  • Baglioni C., Ingram V. M. Abnormal human haemoglobins. V. Chemical investigation of Haemoglobins A, G, C, X from one individual. Biochim. Biophys. Acta 1961; 48: 253
  • Chernoff A. I., Pettit N., Jr. The amino acid composition of hemoglobin. VI. Separation of the tryptic peptides of Hemoglobin Knoxville No. 1 on Dowex-1 X-2 and Sephadex. Biochim. Biophys. Acta 1965; 97: 47–60
  • Bowman B., Barnett D. R., Hodgkinson K. T., Schneider R. G. Chemical characterization of Haemoglobin G St-1. Nature 1966; 211: 1305–1306
  • Minnich V., Cordonnier J. K., Williams W. J., Moore C. V. Alpha, beta and gamma hemoglobin polypeptide chains during the neonatal period with description of a fetal form of Hemoglobin D St. Louis. Blood 1962; 19: 137–167
  • Dance N., Huehns E. R., Shooter E. M. The chemical investigation of Haemoglobin G Bristol and G Bristol/C. Biochim. Biophys. Acta 1964; 86: 144–148
  • Colombo B., Vidal H., Kamuzora H., Lehmann H. A new Haemoglobin J-Habana α71 (E20) AlanineGlutamic acid. Biochim. Biophys. Acta 1974; 351: 1–6
  • Rahbar S., Nowzari G., Daneshmand P. Hemoglobin Daneskgah-Tehran α2 72 (EF1) HistidineArginine β2A. Nature New Biol. 1973; 245: 268–269
  • Pootrakul S., Dixon G. H. Hemoglobin Mahidol: A new hemoglobin α-chain mutant. Can. J. Biochem. 1970; 48: 1066–1078
  • Blackwell R. Q., Liu C.-S. Hemoglobin G Taichung: α74 AspHis. Biochim. Biophys. Acta 1970; 200: 70–75
  • Lorkin P. A., Charlesworth D., Lehmann H., Rahbar S., Tuchinda S., Lie-Injo L. E. Two Haemoglobins Q, α74 (EF3) and α75 (EF4) Aspartic acidHistidine. Br. J. Haematol. 1970; 19: 117–125
  • Orringer E. P., Wilson J. B., Huisman T. H. J. Hemoglobin Chapel Hill or α2 74 AspGly β2. FEBS Lett. 1976; 65: 297–300
  • Vella F., Wiltshire B., Lehmann H., Galbraith P. Hemoglobin Winnipeg α2 75 AspTyr β2. Clin. Biochem. 1973; 6: 66–70
  • Ohba Y., Miyaji T., Matsuoka M., Takeda I., Fukuba Y., Shibata S., Ohkura K. Hemoglobin Matsue-Oki: alpha 75 (EF4) Aspartic acidAsparagine. Hemoglobin 1977; 1: 383–388
  • Van Ros G., Beale D., Lehmann H. Haemoglobin Stanleyville-II (α78 AsparagineLysine). Br. Med. J. 1968; 4: 92–93
  • Rucknagel D. L., Brandt N. J., Spencer H. H. α-Chain mutants of human hemoglobin contributing to the genetics of the α-chain locus. Proc. 1st Inter-American Symposium on Hemoglobins, Caracas, 1969
  • Adams J. G., III, Winter W. P., Rucknagel D. L., Spencer H. H. Biosynthesis of Hemoglobin Ann Arbor: Evidence for catabolic and feedback regulation. Science 1972; 176: 1427–1429
  • Honig G. R., Shamsuddin M., Tremaine L. M., Mason R. G., Vida L. N., Sarnwick R., Shahidi N. T. Hemoglobin Nigeria (α81 SerCys), a new variant having an inhibitory effect on the gelation of a sickle hemoglobin. Blood 1978; 52(Suppl 1)113
  • Winter W. P., Rucknagel D. L., Fielding J. Identification of several rare hemoglobin variants discovered in a population survey including a new variant Hb Garden State α82 AlaAsp. Clin. Res. 1978; 26: 22A
  • Crookston J. H., Farquharson H. A., Beale D., Lehmann H. Hemoglobin Etobicoke: α84 (F5) Serine replaced by Arginine. Can. J. Biochem. 1969; 47: 143–146
  • Huehns E. R. The unstable hemoglobins. Bull. Soc. Chem. Biol. 1970; 52: 1131–1146
  • Lorkin P. A., Huntsman R. G., Ager J. A. M., Lehmann H., Vella F., Darbre P. D. Haemoglobin G Norfolk: α85 (F6) AspAsn. Biochim. Biophys. Acta 1975; 379: 22–27
  • Cohen-Solal M., Manasse B., Thillet J., Rosa J. Haemoglobin G Norfolk α85 (F6) AspAsn. Structural characterization by sequenator analysis and functional properties of a new variant with high oxygen affinity. FEBS Lett. 1975; 50: 163–167
  • Fujiwara N., Maekawa T., Matsuda G. Hemoglobin Atago (α2 85 Tyr β2) a new abnormal human hemoglobin found in Nagasaki. Int. J. Protein Res. 1971; 3: 35–39
  • Reed R. E., Winter W. P., Rucknagel D. L. Haemoglobin Inkster (α2 85 Aspartic acidValine β2) coexisting with β-thalassemia in a Caucasian family. Br. J. Haematol. 1974; 26: 475–484
  • Knuth A., Pribilla W., Marti H. R., Winterhalter K. H. Hemoglobin Moabit: Alpha 86 (F7) LeuArg. A new unstable abnormal hemoglobin. Acta Haematol. 1979; 61: 121–124
  • Miyaji T., Iuchi I., Shibata S., Takeda I., Tamura A. Possible amino acid substitution in the α-chain (α87 Tyr) of Hb M Iwate. Acta Haematol. Jap. 1963; 26: 538–543
  • Heller P., Weinstein H. G., Yakulis V. J., Rosenthal I. M. Hemoglobin M Kankakee, a new variant of Hemoglobin M. Blood 1962; 20: 287–301
  • Pik C., Tonz O. Nature of Haemoglobin M Oldenburg. Nature 1966; 210: 1182
  • De Traverse P. M., Lehmann H., Coquelet M. L., Beale D., Isaacs W. A. Etude d'une hemoglobine J α non encore decrite, dans une famille Francaise. Compt. R. Sceanc. Soc. Biol. 1966; 160: 2270–2272
  • Vella F., Charlesworth D., Lorkin P. A., Lehmann H. Hemoglobin Broussais α90 LysAsn. Can. J. Biochem. 1970; 48: 908–910
  • Braconnier F., Cohen-Solal M., Schlegel N., Blouquit Y., Thillet J., Cassius De Linval J., Rosa J. Hemoglobin J. Broussais α2 90 LysAsn 62 (FG2), decouverte dans une famille Martiniqualse. Nouv. Rev. Fr. D'Hemat. 1975; 15: 333–342
  • Hyde R. D., Kinderlerer J. L., Lehmann H., Hall M. D. Haemoglobin J Rajappen: α90 (FG2) LysThr. Biochim. Biophys. Acta 1971; 243: 515–519
  • Brennan S. O., Tauro G. P., Melrose W., Carrell R. W. Haemoglobin Port Phillip α91 (FG3) LeuPro. A new unstable haemoglobin. FEBS Lett. 1977; 81: 115–117
  • Botha M. C., Beale D., Isaacs W. A., Lehmann H. Haemoglobin J Cape Town α2 92 ArginineGlutamine β2. Nature 1966; 212: 792–795
  • Lines J. G., McIntosh R. Oxygen binding by Haemoglobin J Cape Town (α2 92 ArgGln). Nature 1967; 215: 297–298
  • Clegg J. B., Naughton M. A., Weatherall D. J. Abnormal human haemoglobins. Separation and characterization of the α and β chains by chromatography, and the determination of two new variants, Hb Chesapeake and Hb J (Bangkok). J. Mol. Biol. 1966; 19: 91–108
  • Charache S., Weatherall D. J., Clegg J. B. Polycythemia associated with a hemoglobinopathy. J. Clin. Invest. 1966; 45: 813–822
  • Wajcman H., Belkhodja O., Labie D. Hb Setif: G1(94) αAsp Tyr. A new α chain hemoglobin variant with substitution of the resiude involved in a hydrogen bond between unlike subunits. FEBS Lett. 1972; 27: 298–300
  • Schneider R. G., Atkins R. J., Hosty T. S., Tomlin G., Casey R., Lehmann H., Lorkin P. A., Nagai K. Haemoglobin Titusville: α94 AspAsn, a new haemoglobin with a lowered affinity for oxygen. Biochim. Biophys. Acta 1975; 400: 365–373
  • Schroeder W. A., Shelton J. B., Shelton J. R., Powars D. Hemoglobin Sunshine Seth - α2 (94(G1) AspHis) β2. Hemoglobin 1979; 3: 145–159
  • Huisman T. H. J., Adams H. R., Wilson J. B., Efremov G. D., Reynolds C. A., Wrightstone R. N. Hemoglobin G Georgia or α2 95 Leu (G2) β2. Biochim. Biophys. Acta 1970; 200: 578–580
  • Smith L. L., Plese C. L., Barton B. P., Charache S., Wilson J. B., Huisman T. H. J. Subunit dissociation of the abnormal Hemoglobin G Georgia (α2 95 (G2) β2) and Rampa (α2 95 Ser (G2) β2). J. Biol. Chem. 1972; 247: 1433–1439
  • De Jong W. W. W., Bernini L. F., Meera Khan P. Haemoglobin Rampa: α95 ProSer. Biochim. Biophys. Acta 1971; 236: 197–200
  • Wiltshire B. G., Clark K. G. A., Lorkin P. A., Lehmann H. Haemoglobin Denmark Hill α95 (G2) ProAla, a variant with unusual electrophoretic and oxygen binding properties. Biochim. Biophys. Acta 1972; 278: 459–464
  • Bannister W. H., Grech J. L., Plese C. F., Smith L. L., Barton B. P., Wilson J. B., Reynolds C. A., Huisman T. H. J. Hemoglobin St. Luke's or α2 95 Arg (G2) β2. Eur. J. Biochem. 1972; 29: 301–307
  • Crookston J. H., Farquharson H. A., Kinderlerer J. L., Lehmann H. Hemoglobin Manitoba: α102 (G9) Serine replaced by Arginine. Can. J. Biochem. 1970; 48: 911–914
  • Sanguansermsri T., Matragoon S., Changloah L., Flatz G. Hemoglobin Suan-Dok (α2 109 (G16) LeuArg β2): An unstable variant associated with α-thalassemia. Hemoglobin 1979; 3: 161–74
  • Charache S., Ostertag W. Hemoglobin Hopkins-2 ((α112 Asp) 2 β2): “Low output” protects from potentially harmful effects. Blood 1970; 36: 852
  • Clegg J. B., Charache S. The structure of Hemoglobin Hopkins-2. Hemoglobin 1978; 2: 85–88
  • Niazi G. A., Efremov G. D., Nikolov N., Hunter E., Jr., Huisman T. H. J. Hemoglobin Strumica or α2 112(G19) HisArg β2. (With an addendum: Hemoglobin J Paris-I α2 12 (A10) AlaAsp β2 in the same population.). Biochim. Biophys. Acta 1975; 412: 181–186
  • Beksedic D., Rajevska T., Lorkin P. A., Lehmann H. Hb Serbia (α112(G19) HisArg), a new haemoglobin variant from Yugoslavia. FEB S Lett. 1975; 58: 226–229
  • Gajdusek D. C., Guiart J., Kirk R. L., Carrell R. W., Irvine D., Kynoch P. A. M., Lehmann H. Haemoglobin J Tongariki (α115 AlanineAspartic acid): The first new haemoglobin variant found in a Pacific (Melanesian) population. J. Med. Genet. 1967; 4: 1–6
  • Baglioni C., Lehmann H. Chemical heterogeneity of Haemoglobin O. Nature 1962; 196: 229–232
  • Lie-Injo L. E., Sadono. Haemoglobin O (Buginese X) in Sulawesi. Br. Med. J. 1958; 1: 1461–1462
  • Sansone G., Centa A., Sciarratta V., Gallo E., Lehmann H. Haemoglobin O Indonesia (α116 GluLys) in an Italian family. Acta Haematol. 1970; 43: 40–47
  • Ohba Y., Miyaji T., Matsuoka M., Morito M., Luchi I. Characterization of Hb Ube-4: Alpha 116 (GH4) GluAla. Hemoglobin 1978; 2: 181–186
  • Blackwell R. Q., Boon Wong Hock, Wang C.-L., Weng M.-I., Liu C.-S. Hemoglobin J Meerut: α120 AlaGlu. Biochim. Biophys. Acta 1974; 351: 7–12
  • Kamuzora H., Lehmann H., Griffiths K. D., Mann J. R., Raine D. N. A new haemoglobin variant Hemoglobin J Birmingham α120 (H3) AlaGlu. Ann. Clin. Biochem. 1974; 11: 53–55
  • Moo-Penn W. F., Jue D. L., Johnson M. H., Wilson S. M., Therrel B., Jr., Schmidt R. M. Hemoglobin Tarrant: α126 (H9) AspAsn. A new hemoglobin variant in the α1β1 contact region showing high oxygen affinity and reduced cooperativity. Biochim. Biophys. Acta 1977; 490: 1143–451
  • Vella F., Galbraith P., Wilson J. B., Wong S. C., Folger C. C., Huisman T. H. J. Hemoglobin St. Claude or α2 127 (H10) LysThr β2. Biochim. Biophys. Acta 1974; 365: 318–322
  • Moo-Penn W. F., Bechtel K. C., Johnson M. H., Jue D. L., Holland S., Huff C., Schmidt R. M. Hemoglobin Jackson, α127 (H10) LysAsn. Am. J. Clin. Pathol. 1976; 66: 453–456
  • Kleihauer E. F., Reynolds C. A., Dozy A. M., Wilson J. B., Moores R. R., Berenson M. P., Wright C.-S., Huisman T. H. J. Hemoglobin Bibba or α2 136 Pro β2, an unstable α-chain abnormal hemoglobin. Biochim. Biophys. Acta 1968; 154: 220–222
  • Clegg J. B., Weatherall D. J., Boon Wong Hock, Mustafa D. Two new haemoglobin variants involving proline substitutions. Nature 1969; 222: 379–380
  • Poyart C., Krishnamoorthy R., Bursaux E., Gacon G., Labia D. Structural and functional studies of Haemoglobin Suresnes or α2 141 (HC3) ArgHis β2, a new high oxygen affinity mutant. FEBS Lett. 1976; 69: 103–107
  • Saenz G. F., Elizondo J., Alvarado M. A., Atmetlla F., Arroys G., Martinez G., Lima F., Colombo B. Chemical characterization of a new haemoglobin variant Haemoglobin J Cubujuqui (α2 141 (HC3) ArgSer β2). Biochim. Biophys. Acta 1977; 494: 48–50
  • Mavilio F., Marinucci M., Tentori L., Fontanarosa P. P., Rossi U., Biagiotti S. Hemoglobin Legnano (α2 141 (HC3) ArgLeu β2): A new abnormal hemoglobin with high oxygeh affinity. Hemoglobin 1978; 2: 249–259
  • Martinez G., Lima F., Residenti C., Colombo B. Hb J Camaguey α2 141 (HC3) ArgGly β2. A new abnormal human hemoglobin. Hemoglobin 1978; 2: 47–52
  • Moo-Penn W. F., Bechtel K. C., Schmidt R. M., Johnson M. H., Jue D. L., Schmidt D. E., Jr., Dunlap W. M., Opella S. J., Bonaventura J., Bonaventura C. Hemoglobin Raleigh (β1 ValineAcetylalanine). Structural and functional characterization. Biochemistry 1977; 16: 4872–4879
  • Labossiere A., Vella F., Hiebert J., Galbraith P. Hemoglobin Deer Lodge: α,β, 2 HisArg. Clin. Biochem. 1972; 5: 46–50
  • Ingram V. M. Abnormal human haemoglobins. III. The chemical difference between normal and sickle cell haemoglobins. Biochim. Biophys. Acta 1959; 36: 402–411
  • Hunt J. A., Ingram V. M. Abnormal human haemoglobins. IV. The chemical difference between normal human haemoglobin and Haemoglobin C. Biochim. Biophys. Acta 1960; 42: 409–421
  • Blackwell R. Q., Oemijati S., Pribadi W., Wang M.-I., Liu C.-S. Hemoglobin G Makassar: β6 GluAla. Biochim. Biophys. Acta 1970; 214: 396–401
  • Hill R. L., Swenson R. T., Schwartz H. C. Characterization of a chemical abnormality in Hemoglobin G. J. Biol. Chem. 1960; 235: 3182–3187
  • Tuchinaa S., Beale D., Lehmann H. A new haemoglobin in a Thai family. A case of Haemoglobin Siriraj-β-thalassemia. Br. Med. J. 1965; 1: 1583–1585
  • Bonaventura J., Riggs A. Polymerization of hemoglobins of mouse and man. Structural basis. Science 1967; 158: 800–802
  • Tondo C. V., Bonaventura J., Bonaventura C., Brunori M., Antonini E. Functional properties of Hemoglobin Porto Alegre (αA2β92 SerCys) and the reactivity of its extra cysteinyl residue. Biochim. Biophys. Acta 1974; 342: 15–20
  • Arcasoy A., Casey R., Lehmann H., Cavdar A. O., Berki A. A new Haemoglobin J from Turkey - Hb Ankara (β10 (A7) AlaAsp). FEB S Lett. 1974; 42: 121–123
  • Monn E., Gaffney P. J., Lehmann H. Haemoglobin Sögn (β14 Arginine). A new haemoglobin variant. Scand. J. Haematol. 1968; 5: 353–360
  • Beuzard Y., Basset P., Braconnier F., El Gammel H., Martin L., Oudard J. L., Thillet J. Haemoglobin Saki α2β2 14 LeuPro (A11) structure and function. Biochim. Biophys. Acta 1975; 393: 182–187
  • Milner P. F., Corley C. C., Pomeroy W. L., Wilson J. B., Gravely M., Huisman T. H. J. Thalassemia intermedia caused by heterozygosity for both β-thalassemia and Hemoglobin Saki (β14 (A11) LeuPro). Am. J. Hematol. 1976; 1: 283–292
  • Kennedy C. C., Blundell G., Lorkin P. A., Lang A., Lehmann H. Haemoglobin Belfast 15 (A12) TryptophanArginine: A new unstable haemoglobin variant. Br. Med. J. 1974; 4: 324–326
  • Gacon G., Wajcman H., Labie D., Varet B., Christoforov B. A second case of Haemoglobin Belfast (β15 [A12] TrpArg) observed in a French patient. Acta Haematol. 1976; 55: 313–319
  • Baglioni C., Weatherall D. J. Abnormal human hemoglobins. IX. Chemistry of Hemoglobin J Baltimore. Biochim. Biophys. Acta 1963; 78: 637–643
  • Weatherall D. J. Hemoglobin J (Baltimore) coexisting in a family with Hemoglobin S. Johns Hopkins Hosp. Bull. 1964; 114: 1–12
  • Chernoff A. I., Perillie P. E. The amino acid composition of HGB New Haven #12 (HGB N New Haven). Biochem. Biophys. Res. Commun. 1964; 16: 368–372
  • Wong S. C., Bouver N., Wilson J. B., Huisman T. H. J. Hb J Georgia = Hb J Baltimore = α2β2 16 GlyAsp. Clin. Chim. Acta 1971; 35: 521–522
  • Wade P. T., Jenkins T., Huehns E. R. Haemoglobin variant in a Bushman: Haemoglobin D a Bushman α22 16 GlyArg. Nature 1967; 216: 688–690
  • Maekawa M., Maekawa T., Fujiwara N., Tabara K., Matsuda G. Hemoglobin Nagasaki: αA2β2 17 Glu. A new abnormal human hemoglobin found in one family in Nagasaki. Int. J. Prot. Res. 1970; 11: 147–156
  • Elion J., Belkhodja O., Wajcman H., Labie D. Two variants of Hemoglobin D in the Algerian population: Hemoglobin D Ouled Rabah β19 (B1) AsnLys and Hemoglobin D Iran β22 (B4) GIuGln. Biochim. Biophys. Acta 1973; 310: 360–364
  • Lam H., Wilson J. B., Harris H., Gravely M., Huisman T. H. J. Hemoglobin Alamo [α2β2 19 (B1) AsnAsp]. Hemoglobin 1977; 1: 703–706
  • Stamatoyannopoulos G., Nute P. E., Adamson J. W., Bellingham A. J., Funk D., Hornung S. Hemoglobin Olympia (β20 ValineMethionine) : An electrophoretically silent variant associated with high oxygen affinity and erythrocytosis. J. Clin. Invest. 1973; 52: 342–349
  • Vella F., Lorkin P. A., Carrell R. W., Lehmann H. A new hemoglobin variant resembling Hemoglobin E. Hemoglobin E Saskatoon: β22 GluLys. Can. J. Biochem. 1967; 45: 1385–1391
  • Blackwell R. Q., Yang H. J., Wang C. C. Hemoglobin G Taipei: α2β2 22 GIuGly. Biochim. Biophys. Acta 1969; 175: 237–241
  • Vella F., Isaacs W. A., Lehmann H. Hemoglobin G Saskatoon: β22 GluAla. Can. J. Biochem. 1967; 45: 351–353
  • Blackwell R. Q., Liu C. S., Yang H. J., Wang C. C., Huang J. T. H. Hemoglobin variant common to Chinese and North American Indians: α2β2 22 Glu-Ala. Science 1968; 161: 381–382
  • Bowman B. H., Barnett D. R., Hite R. Hemoglobin G Coushatta: a beta variant with a delta-like substitution. Biochem. Biophys. Res. Commun. 1967; 26: 466–470
  • Blackwell R. Q., Ro I. H., Liu C. S., Yang H. J., Wang C. C., Huang J. T. H. Hemoglobin variant found in Koreans, Chinese, and North American Indians. α2β2 22 GluAla. Am. J. Phys. Anthropol. 1969; 30: 389–392
  • Rahbar S., Haemoglobin D. Iran. β22 Glutamic acidGlutamine (B4). Br. J. Haematol. 1973; 24: 31–35
  • Garet M. C., Blouquit Y., Arous N., Rosa J. Hb Strasbourg α2β2 20 (B2) ValAsp: A variant at the same locus as Hb Olympia β20 ValMet. FEBS Lett. 1976; 72: 1–4
  • Forget B. G. Nucleotide sequence of human β globin messenger RNA. Hemoglobin 1977; 1: 879–881
  • Ranney H. M., Jacobs A. S., Udem L., Zalusky R. Hemoglobin Riverdale-Bronx, an unstable hemoglobin resulting from the substitution of arginine for glycine at helical residue B6 of the β polypeptide chain. Biochim. Biophys. Acta 1968; 33: 1004–1011
  • Huisman T. H. J., Brown A. K., Efremov G. D., Wilson J. B., Reynolds C. A., Uy R., Smith L. L. Hemoglobin Savannah (B6(24) β-GlycineValine): An unstable variant causing anemia with inclusion bodies. J. Clin. Invest. 1971; 50: 650–659
  • Idelson L. I., Didkowsky N. A., Casey R., Lorkin P. A., Lehmann H. New unstable haemoglobin (Hb Moscva, β24 (B6) GlyAsp) found in the U.S.S.R. Nature 1974; 249: 768–770
  • Blackwell R. Q., Liu C.-S. Hemoglobin G Taiwan-Ami α2β2 25 GlyArg. Biochem. Biophys. Res. Commun. 1968; 30: 690–696
  • Hunt J. A., Ingram V. M. Abnormal human haemoglobins. VI. The chemical difference between Haemoglobins A and E. Biochim. Biophys. Acta 1961; 49: 520–536
  • Blouquit Y., Arous N., Machado P. E. A., Garel M. C. Hb Henri Mondor: β26 (B8) GluVal: A variant with a substitution localized at the same position as that of Hb E β26 GluLys. FEBS Lett. 1976; 72: 5–7
  • Idelson L. I., Didkovsky N. A., Filippova A. V., Casey R., Kynoch P. A. M., Lehmann H. Haemoglobin Volga, β27 (B9) AlaAsp, a new highly unstable haemoglobin with a suppressed charge. FEBS Lett. 1975; 58: 122–125
  • Kuis-Reerink J. D., Jonxis J. H. P., Niazi G. A., Wilson J. B., Bolch K. C., Gravely M., Huisman T. H. J. Hb Volga or a α2β2 27 (B9) AlaAsp: An unstable hemoglobin variant in three generations of a Dutch family. Biochim. Biophys. Acta 1976; 439: 63–69
  • Cohen-Solal M., Seligmann M., Thillet J., Rosa J. Haemoglobin Saint Louis β28 (B10) LeucineGlutamine. A new unstable haemoglobin only present in a ferri form. Abstract 408, XIV Intl. Cong. Hematol., Sao Paulo, 1972. FEBS Lett. 1973; 33: 37–41
  • Thillet J., Cohen-Solal M., Seligmann M., Rosa J. Functional and physicochemical studies of Hemoglobin St. Louis β2B (B10) LeuGln. J. Clin. Invest. 1976; 58: 1098–1106
  • Sansone G., Carrell R. W., Lehmann H. Haemoglobin Genova: 028 (B10) LeucineProline. Nature 1967; 214: 877–879
  • Schmidt R. M., Bechtel K. C., Johnson M. H., Therrell B. J., Jr., Moo-Penn W. F. Hemoglobin Lufkin: β29 (B11) GlyAsp: An unstable hemoglobin variant involving an internal amino acid residue. Hemoglobin 1977; 1: 799–814
  • Brimhall B., Jones R. T., Baur E. W., Motulsky A. G. Structural characterization of Hemoglobin Tacoma. Biochemistry 1969; 8: 2125–2129
  • Jackson J. M., Yates A., Huehns E. R. Haemoglobin Perth: β32 (B14) LeuPro. An unstable haemoglobin causing haemolysis. Br. J. Haematol. 1973; 25: 607–610
  • Honig G. R., Green D., Shamsuddin M., Vida L. N., Mason R. G., Gnarra D. J., Maurer H. S. Hemoglobin Abraham Lincoln, β32 (B14) LeucineProline. An unstable variant producing severe hemolytic disease. J. Clin. Invest. 1973; 52: 1746–1755
  • Garel M. C., Blouquit Y., Rosa J. Hemoglobin Castilla β32 (B14) LeuArg: A new unstable variant producing severe hemolytic disease. FEBS Lett. 1975; 58: 145–147
  • Rieder R. F., Oski F. A., Clegg J. B. Hemoglobin Philly (β35 TyrosinePhenylalanine): Studies in the molecular pathology of hemoglobin. J. Clin. Invest. 1969; 48: 1627–1642
  • Yamaoka K. Hemoglobin Hirose: α2β2 37 (C3) Tryptophan yielding Serine. Blood 1971; 38: 730–738
  • Gacon G., Belkhodja O., Wajcman H., Labie D. Structural and functional studies of Hb Rothschild β37 (C3) TrpArg. A new variant of the α1β2 contact. FEBS Lett. 1977; 82: 243–246
  • Brimhall B., Jones R. T., Schneider R. G., Hosty T. S., Tomlin G., Atkins R. Two new hemoglobins: Hemoglobin Alabama (β39 (C5) GlnLys) and Hemoglobin Montgomery (β48 (CD6) LeuArg). Biochim. Biophys. Acta 1975; 379: 28–32
  • Kendall A. G., Pas A. T., Wilson J. B., Cope N., Bolch K., Huisman T. H. J. Hb Vaasa or α2β2 (39 (C5) GlnGlu), a mildly unstable variant found in a Finnish family. Hemoglobin 1977; 1: 292–295
  • Brown W. J., Niazi G. A., Jayalakshmi M., Abraham E. G., Huisman T. H. J. Hemoglobin Athens-Georgia, or α2β2 40 (C6) ArgLys, a hemoglobin variant with an increased oxygen affinity. Biochim. Biophys. Acta 1976; 439: 70–76
  • Moo-Penn W. F., Johnson M. H., Bechtel K. C., Jun D. L., Therrell B. L., Schmidt R. M. Hemoglobin Austin and Waco: Two hemoglobins with substitutions in the α1β2 contact region. Arch. Biochem. Biophys. 1977; 179: 86–94
  • Burkett L. B., Sharma V. S., Pisciotta A. V., Ranney H. M., Bruckheimer S. Hemoglobin Mequon 041 (C7) PhenylalanineTyrosine. Blood 1976; 48: 645–651
  • Dacie J. V., Shinton N. K., Gaffney P. J., Jr., Carrell R. W., Lehmann H. Haemoglobin Hammersmith (β42 (CD1) PheSer). Nature 1967; 216: 663–665
  • Ohba Y., Miyaji T., Matsuoka M., Yamaguchi K., Yonemitsu H., Ishii T., Shibata S. Hemoglobin Chiba: Hb Hammersmith in a Japanese girl. Acta Haematol. Jap. 1975; 38: 53–58
  • Keeling M. M., Ogdon L. L., Wrightstone R. N., Wilson J. B., Reynolds C. A., Kitchens J. L., Huisman T. H. J. Hemoglobin Louisville (β42 (CD1) PheLeu): An unstable variant causing mild hemolytic anemia. J. Clin. Invest. 1971; 50: 2395–2402
  • Bratu V., Lorkin P. A., Lehmann H., Predescu C. Haemoglobin Bucuresti β42 (CD1) PheLeu, a cause of unstable haemoglobin haemolytic anaemia. Biochim. Biophys. Acta 1971; 251: 1–6
  • Bowman B. H., Oliver C. P., Barnett D. R., Cunningham J. R., Schneider R. G. Chemical characterization of three Hemoglobins G. Blood 1964; 23: 193–199
  • Iuchi I., Ueda S., Hidaka K., Shibata S. Hemoglobin Hoshida (β43 (CD2) GluGln), a new hemoglobin variant discovered in Japan. Hemoglobin 1978; 2: 235–247
  • Allan N., Beale D., Irvine D., Lehmann H. Three Haemoglobins K: Woolwich, an abnormal, Cameroon and Ibadan, two unusual variants of human Haemoglobin A. Nature 1965; 208: 658–661
  • Sick K., Beale D., Irvine D., Lehmann H., Goodall P. T., MacDougall S. Haemoglobin G Copenhagan and Haemoglobin J Cambridge. Two new β-chain variants of Haemoglobin A. Biochim. Biophys. Acta 1967; 140: 231–242
  • Marinucci M., Mavilio F., Tentori L., Alberti R. Hemoglobin Gavello α2β2 47 (CD6) AspGly, a new hemoglobin variant from Polesine (Italy). Hemoglobin 1977; 1: 771–779
  • Rahbar S., Nowzari G., Ala F. Haemoglobin Avicenna (347 (CD6) AspAla), a new abnormal haemoglobin. Biochim. Biophys. Acta 1979; 576: 466–470
  • Charache S., Brimhall B., Milner P., Cobb L. Hemoglobin Okaloosa (β48 (CD7) LeucineArginine). An unstable hemoglobin with decreased oxygen affinity. J. Clin. Invest. 1973; 52: 2858–2864
  • Labossiere A., Hill J. R., Vella F. A new βTp V hemoglobin variant: Hb Edmonton. Clin. Biochem. 1971; 4: 114–117
  • Jones R. T., Koler R. D., Duerst M. L., Dhindsa D. S. Hemoglobin Williamette [α2β2 51 ProArg (D2)] a new abnormal human hemoglobin. Hemoglobin 1976; 1: 45–57
  • Konotey-Ahulu F. I. D., Kinderlerer J. L., Lehmann H., Ringelhann B. Haemoglobin Osu-Christiansborg: A new β-chain variant of Haemoglobin A (β52 (D3) Aspartic acidAsparagine) in combination with haemoglobin S. J. Med. Gent. 1971; 8: 302–305
  • Beresford C. H., Clegg J. B., Weatherall D. J. Haemoglobin Ocho Rios (β52 (D3) Aspartic acidAlanine); a new β-chain variant of Haemoglobin A found in combination with Haemoglobin S. J. Med. Genet. 1972; 9: 151–153
  • Clegg L. B., Naughton M. A., Weatherall D. J. Abnormal human haemoglobins. Separation and characterization of the α and β chains by chromatography, and the determination of two new variants. J. Mol. Biol. 1966; 19: 91–108
  • Blackwell R. Q., Liu C.-S. The identical structural anomalies of Hemoglobins J Meinung and J Korat. Biochem. Biophys. Res. Commun. 1966; 24: 732–738
  • Blackwell R. Q., Liu C.-S., Lie-Injo L. E., Pribadi W. Fast hemoglobin variant in Minahassan people of Sulawesi, Chinese and Thais: α2β2 56 GlyAsp. Am. J. Phys. Anthropol. 1970; 32: 147–150
  • Rahbar S., Nowzari G., Haydari H., Daneshmand P. Haemoglobin Hamadan α2Aβ2 56 Glycine-Arginine (D7). Biochim. Biophys. Acta 1975; 379: 645–648
  • Giardina B., Brunori M., Antonini E., Tentori L. Properties of Hemoglobin G Ferrara ((β57 (E1) AsnLys). Biochim. Biophys. Acta 1978; 534: 1–6
  • Marengo-Rowe A. J., Lorkin P. A., Gallo E., Lehmann H. Haemoglobin Dhofar - a new variant from Southern Arabia. Biochim. Biophys. Acta 1968; 168: 58–63
  • Boulton F. E., Huntsman R. G., Lehmann H., Lorkin P., Romero Herrera A. Myoglobin variants. Br. J. Haematol. 1971; 20: 671–672
  • Blackwell R. Q., Liu C.-S., Shih T.-B. Hemoglobin J Kaohsiung: β59 LysThr. Biochim. Biophys. Acta 1971; 229: 343–348
  • Blackwell R. Q., Jim R. T. S., Liu C.-S., Wong M.-I., Wang C.-L., Shih T.-B. Fast hemoglobin variant found in Hawaiian-Chinese-Caucasian family in Hawaii and a Chinese subject in Taiwan. Vox. Sang. 1972; 22: 469–473
  • Wajcman H., Amegnizin K. P. E., Belkhodja O., Labie D. Hemoglobin J Lome β59 (E3) LysAsn. A new fast moving variant found in a Togolese. FEBS Lett. 1977; 84: 372–374
  • Kagimoto T., Morino Y., Kishimoto S. A new hemoglobin variant Hb Yatsushiro α2Aβ2 60 ValLeu. Biochim. Biophys. Acta 1978; 532: 195–198
  • Jones R. T., Brimhall B., Huehns E. R., Motulsky A. G. Structural characterization of Hemoglobin N Seattle: α2Aβ2 61 LysGlu. Biochim. Biophys. Acta 1968; 154: 278–283
  • Shibata S., Miyaji T., Iuchi I., Ueda S., Takeda I. Hemoglobin Hikari (α2Aβ2 61 Asp-NH2): A fast moving hemoglobin found in two unrelated Japanese families. Clin. Chim. Acta 1964; 10: 101–105
  • Beutler E., Lang A., Lehmann H. Hemoglobin Duarte: α2β2 62 (E6) AlaPro: A new unstable hemoglobin with increased oxygen affinity. Blood 1974; 113: 527–535
  • Muller C. J., Kingma S. Haemoglobin Zürich α2Aβ263 Arg. Biochim. Biophys. Acta 1961; 50: 595
  • Gerald P. S., Efron M. L. Chemical studies of several varieties of Hb M. Proc. Natl. Acad. Sci. USA 1961; 47: 1758–1767
  • Shibata S., Miyaji T., Iuchi I., Ueda S. A comparative study of Hemoglobin M Iwate and Hemoglobin M Kurume by means of electrophoresis, chromatography and analysis of peptide chains. Acta Haematol. Jap. 1961; 24: 486–494
  • Murawski K., Szymanowska Z., Kozlowska J. A new variant of abnormal methaemoglobin: Hb M Radom. Biochim. Biophys. Acta 1963; 69: 442–444
  • Hobolth N., Haemoglobinm M. Arhus I. Clinical family study. Acta Paediatr. Scand. 1965; 54: 357–362
  • Josephson A. M., Weinstein H. G., Yakulis V. J., Singer L., Heller P. A new variant of Hemoglobin M disease: Hemoglobin M Chicago. J. Lab. Clin. Med. 1962; 59: 918–925
  • Betke K., Gröschner E., Bock K. Properties of a further variant of Haemoglobin M. Nature 1960; 188: 864–865
  • Hörlein H., Weber G. Über chronishe familiäre methämoglobinämie und eine neue modifikation des methämoglobins. Deutsche Medizinische Wochenschrift 1948; 73: 476–478
  • Efremov G. D., Huisman T. H. J., Stanulovic M., Zurovec M., Duma H., Wilson J. B., Jeremic V. Haemoglobin M Saskatoon and Haemoglobin M Hyde Park in two Yugoslavian families. Scand. J. Haematol. 1974; 13: 48–60
  • Kohne E., Grosze H. P., Versmold H., Kley H. P., Kleihauer E. Hb M Erlangen: α2β2 63 (E7) Tyr. Eine neue mutation mit hämolyse and diaphorasemangel. Kinderheilk 1975; 120: 69–78
  • Wajcman H., Krishnamoorthy R., Gacon G., Elion J., Allard C., Labie D. A new hemoglobin variant involving the distal histidine: Hb Bicetre (β63 (E7) His-Pro). J. Mol. Med. 1976; 1: 187–197
  • Tentori L. Three examples of double heterozygosis beta-thalassemia and rare hemoglobin variants. Intl. Symp. Abnormal Hemoglobin and Thalassemia. Istanbul, Turkey, 1974, Abstract 685
  • Ricco G., Pich P. G., Mazza U., Rossi G., Ajmar F., Arese P., Gallo E. Hb J Sicilia: β65 (E9) LysAsn, a beta homologue of Hb Zambia. FEBS Lett. 1974; 39: 200–204
  • Garel M. C., Hassan W., Coquelet M. T., Goossens M., Rosa J. Hemoglobin J Cairo: β65 (E9) LysGln, a new hemoglobin variant discovered in an Egyptian family. Biochim. Biophys. Acta 1976; 420: 97–104
  • Rosa J., Labie D., Wajcman H., Boigne J. M., Cabannes R., Bierme R., Ruffle J. Haemoglobin I Toulouse: β66 (E10) LysGlu: A new abnormal haemoglobin with a mutation localized on the E10 porphyrin surrounding zones. Nature 1969; 223: 190–191
  • Steadman J. H., Yates A., Huehns E. R. Idiopathic Heinz body anaemia: Hb-Bristol (β67 (E11) ValAsp). Br. J. Haematol. 1970; 18: 435–446
  • Carrell R. W., Lehmann H., Lorkin P. A., Raik E., Hunter E. Haemoglobin Sydney: β67 (E11) ValineAlanine: An emerging pattern of unstable haemoglobins. Nature 1967; 215: 626–628
  • Ohba Y., Miyaji T., Matsuoka M., Sugiyama K., Suzuki T., Sugiura T. Hemoglobin Mizuho or beta 68 (E12), LeucineProline, a new unstable variant associated with severe hemolytic anemia. Hemoglobin 1977; 1: 467–477
  • Salomon H., Tatarski I., Dance N., Huehns E. R., Shooter E. M. A new hemoglobin variant found in a Beduin tribe: Hemoglobin “Rambam.” Israel. J. Med. Sci. 1965; 1: 836–840
  • Kurachi S., Hermodson M., Hornung S., Stamatoyannopoulos G. Structure of Haemoglobin Seattle. Nature New Biol. 1973; 243: 275–276
  • Carrell R. W., Owen M. C. A new approach to haemoglobin variant identification. Haemoglobin Christchurch β71 (E15) PhenylalanineSerine. Biochim. Biophys. Acta 1971; 236: 507–511
  • Jones R. T., Brimhall B., Pootrakul S., Gray G. Hemoglobin Vancouver [α2β2 73 (E17) AspTyr]: Its structure and function. J. Mol. Evol. 1976; 9: 37–44
  • Konotey-Ahulu F. I. D., Gallo E., Lehmann H., Ringelhann B. Haemoglobin Korle-Bu (β73 Aspartic acidAsparagine) showing one of the two amino acid substitutions of Haemoglobin C Harlem. J. Med. Genet. 1968; 5: 107–111
  • Bio-Doku F. S., Kinderlerer J., Lehmann H. Atlas of Protein Sequence and Structure 1972; 5: 73
  • Schneider R. G., Hosty T. S., Tomlin G., Atkins R., Brimhall B., Jones R. T. Hb Mobile [α2β2 73 (E17) AspVal]: A new variant. Biochem. Genet. 1975; 13: 411–415
  • Rieder R. F., Wolf D. J., Clegg J. B., Lee S. L. Rapid post-synthetic destruction of unstable Haemoglobin Bushwick. Nature 1975; 254: 725–727
  • White J. M., Brain M. C., Lorkin P. A., Lehmann H., Smith M. Mild “unstable haemoglobin haemolytic anaemia” caused by Haemoglobin Shepherds Bush (β74 (E18) Gly-Asp). Nature 1970; 225: 939–941
  • Hubbard M., Winton E. F., Lindeman J. G., Dessauer P. L., Wilson J. B., Wrightstone R. N., Huisman T. H. J. Hemoglobin Atlanta or α2β2 75 LeuPro (E19): An unstable variant found in several members of a Caucasian family. Biochim. Biophys. Acta 1975; 386: 538–541
  • Romain P. L., Schwartz A. D., Shamsuddin M., Adams J. G., III, Mason R. G., Vida L. N., Honig G. R. Hemoglobin J-Chicago (β76 (E20) AlaAsp): A new hemoglobin variant resulting from a substitution of an external residue. Blood 1975; 45: 387–393
  • Rahbar S., Beale D., Isaacs W. A., Lehmann H. Abnormal haemoglobins in Iran. Observation of a new variant - Haemoglobin J Iran (α2β2 77 HisArg). Brit. Med. J. 1967; 1: 674–677
  • Blackwell R. Q., Shih T.-B., Wang C.-L., Liu C.-S. Hemoglobin G-Hsi-Tsou: β79 AspGly. Biochim. Biophys. Acta 1972; 257: 49–53
  • Benesch R., Edilji R., Benesch R. E. Oxygenation properties of hemoglobin variants with substitutions near the polyphosphate binding site. Biochim. Biophys. Acta 1975; 393: 368
  • Blackwell R. Q., Yang H. T., Wang C. C. Hemoglobin G-Szuhu: β80 AsnLys. Biochim. Biophys. Acta 1969; 188: 59–64
  • Imai K., Morimoto H., Kotani M., Shibata S., Miyaji T., Masutomo K. Studies on the function of abnormal hemoglobins. II. Oxygen equilibrium of abnormal hemoglobins: Shimonaseki, Ube II, Hikari, Gifu, and Agenogi. Biochim. Blophys. Acta 1970; 200: 197–202
  • Schneider R. C., Hettig R. A., Bilunos M., Brimhall B. Hemoglobin Baylor (α2β2 81 (EF5) LeuArg] – an unstable mutant with high oxygen affinity. Hemoglobin 1976; 1: 85–96
  • Moo–Penn W. F., Jun D. L., Bechtel K. C., Johnson M. H., Schmidt R. M., McCurdy P. R., Fox J., Bonaventura J., Sullivan B., Bonaventura C. Hemoglobin Providence. A human hemoglobin variant occurring in two forms in vivo. J. Biol. Chem. 1976; 251: 7557–7562
  • Bonaventura J., Bonaventura C., Sullivan B., Ferruzzi G., McCurdy P. R., Fox J., Moo-Penn W. F. Hemoglobin Providence. Functional consequences of two alterations of the 2,3-diphosphoglycerate binding site at position β82. J. Biol. Chem. 1976; 251: 7563–7571
  • Lorkin P. A., Stephens A. D., Beard M. E. J., Wrigley P. F. M., Adams L., Lehmann H. Haemoglobin Rahere (β82 LysThr): A new high affinity haemoglobin associated with decreased 2,3-diphosphoglycerate binding and relative polycythaemia. Br. Med. J. 1975; 4: 200–202
  • Ikkala E., Koskela J., Pikkarainen P., Rahiala E.-L., El-Hazmi M. A. F., Nagai K., Lang A., Lehmann H. Hb Helsinki: A variant with a high oxygen affinity and a substitution at a 2,3-DPG binding site (β82 [EF6] LysMet). Acta Haematol. 1976; 56: 257–275
  • Blackwell R. Q., Liu C.-S., Wang C.-L. Hemoglobin Ta-li: β83 GlyCys. Biochim. Biophys. Acta 1971; 243: 467–474
  • Tatsis B., Sofroniadou K., Stergiopoulos C. I. Hemoglobin Pyrgos (α2β2 83 (EF7) GlyAsp). A new hemoglobin (Hb) variant. Annual Meeting of the American Society of Hematology, Miami, 1972, Abstract 168
  • Tatsis B., Sofroniadou K., Stergiopoulos C. I. Hemoglobin Pyrgos α2β2 83 (EF7) GlyAsp: A new hemoglobin variant in double heterozygosity with Hemoglobin S. Blood 1976; 47: 827–832
  • Bradley T. B., Wohl R. C., Murphy S. B., Oski F. A., Bunn H. F. Properties of Hemoglobin Bryn Mawr, β85 PheSer, a new spontaneous mutation producing an unstable hemoglobin with high oxygen affinity. Annual Meeting of the American Society of Hematology, Miami, 1972, Abstract 40
  • de Weinstein B. I., White J. M., Wiltshire B. G., Lehmann H. A new unstable haemoglobin: Hb Buenos Aires, 585 (Fl) PheSer. Acta Haematol. 1973; 50: 357–363
  • Watson-Williams E. J., Beale D., Irvine D., Lehmann H. A new haemoglobin, D Ibadan (β87 ThreonineLysine), producing no sickle cell Haemoglobin D disease with haemoglobin S. Nature 1965; 205: 1273–1276
  • Hollender A., Lorkin P. A., Lehmann H., Svensson B. New unstable Haemoglobin Boras: β88 (F4) LeucineArginine. Nature 1969; 222: 953–955
  • Opfell R. W., Lorkin P. A., Lehmann H. Hereditary nonspherocytic haemolytic anaemia with post-splenectomy inclusion bodies and pigmenturia caused by an unstable Haemoglobin Santa Ana – β88 (F4) LeucineProline. J. Med. Genet. 1968; 5: 292–297
  • Thillet J., Blouquit Y., Garel M. C., Dreyfus B., Reyes F., Cohen-Solal M., Beuzard Y., Rosa J. Hemoglobin Creteil β89 (F5) SerAsn: High oxygen affinity variant of hemoglobin frozen in a quaternary R-structure. J. Mol. Med. 1976; 1: 135–150
  • Paniker N. V., Kuang-Tzu Davis Lin Krantz S.B., Flexner J. M., Wasserman B. K., Puett D. Haemoglobin Vanderbilt (α2β2 89 SerArg): A new haemoglobin with high oxygen affinity and compensatory erythrocytosis. Br. J. Haematol. 1978; 39: 249–258
  • Miyaji R., Suzuki H., Ohba Y., Shibata S. Hemoglobin Agenogi (α2β2 90 Lys), a slow moving hemoglobin of a Japanese family resembling Hb-E. Clin. Chim. Acta 1966; 14: 624–629
  • Schneider R. G., Satoshi U., Alperine J. B., Brimhall B., Jones R. T. Hemoglobin Sabine, β91 (F7) LeuPro. An unstable variant causing severe anemia with inclusion bodies. N. Engl. J. Med. 1969; 280: 739–745
  • Ahern E., Ahern C., Hilton T., Serjeant G. R., Serjeant B. E., Seakins M., Lang A., Middleton A., Lehmann H. Haemoglobin Caribbean β91 (F7) LeuArg: A mildly unstable haemoglobin with low oxygen affinity. FEBS Lett. 1976; 69: 99–102
  • Heller P., Coleman R. D., Yakulis V. Hemoglobin M Hyde Park: A new variant of abnormal methemoglobin. J. Clin. Invest. 1966; 45: 1021
  • Shibata S., Yamamoto K., Ohba Y., Miyaji R., Karita K., Iuchi I. Hemoglobin M Akita disease. Acta Haematol. Jap. 1969; 32: 311–329
  • Beuzard Y., Courvalin J. Cl., Cohen-Solal M., Garel M. C., Rosa J., Brizard C. P., Gibaud A. Structural studies of Hemoglobin Saint Etienne β92 (F8) HisGln: A new abnormal hemoglobin with loss of β proximal histidine and absence of heme on the β chains. FEBS Lett. 1972; 27: 76–80
  • Aksoy M., Erdem S., Efremov G. D., Wilson J. B., Huisman T. H. J., Schroeder W. A., Shelton J. R., Shelton J. B., Ulitin O. N., Muftuglu A. Hemoglobin Istanbul: Substitution of Glutamine for Histidine in a proximal Histidine (F8(92) β). J. Clin. Invest. 1972; 51: 2380–2387
  • Adams J. G., III, Przywara K. P., Heller P., Shamsuddin M. Hemoglobin J Atigeld Gardens: A hemoglobin variant with a substitution of the proximal histidine of the β-chain. Hemoglobin 1978; 2: 403–415
  • Finney R., Casey R., Lehmann H., Walker W. Hb Newcastle: β92 (F8) HisPro. FEBS Lett. 1975; 60: 435–438
  • Clegg J. B., Naughton M. A., Weatherall D. J. An improved method for the characterization of human haemoglobin mutants: Identification of α2β2 95 Glu, Haemoglobin N (Baltimore). Nature 1965; 207: 945–947
  • Gottlieb A. J., Robinson E. A., Itano H. A. Primary structure of Hopkins-I haemoglobin. Nature 1967; 214: 189–190
  • Dobbs N. B., Jr., Simmons J. W., Wilson J. B., Huisman T. H. J. Hemoglobin Jenkins or Hemoglobin N-Baltimore or α2β2 95 Glu. Biochim. Biophys. Acta 1966; 117: 492–494
  • Bayrakci Josephson A., Singer L., Heller P., Coleman R. D. A new fast hemoglobin. Xth Congress of the International Society of Haematology, StockholmSweden, 1964
  • Hamilton H. H., Iuchi I., Miyaji T., Shibata S. Hemoglobin Hiroshima (β143 HistidineAspartic acid): A newly identified fast moving beta chain variant associated with increased oxygen affinity and compensatory erythremia. (Personal communication, P. Heller.). J. Clin. Invest. 1969; 48: 525–535
  • Moo-Penn W. F., Schneider R. G., Andrian S., Das D. K. Hemoglobin Detroit: 895 (FG2) Lysine-Asparagine. Biochim. Biophys. Acta 1978; 536: 283–288
  • Lorkin P. A., Lehmann H., Fairbanks V. F., Berglund G., Leonhardt T. Two new pathological haemoglobins: Olmsted β141 (H19) LeuArg and Malmo: 897 (FG4) HisGln. Biochem. J. 1970; 119: 68–74
  • Taketa F., Huang Y. P., Libnoch J. A., Dessell B. H. Hemoglobin Wood β97 (FG4) HisLeu: A new high-oxygen affinity hemoglobin associated with familial erythrocytosis. Biochim. Biophys. Acta 1975; 400: 348–353
  • Taketa F., Antholine W. E., Mauk A. G., Libnoch J. A. Nitrosylhemoglobin Wood: Effects of inositol hexaphosphate on thiol reactivity and electron paramagnetic resonance spectrum. Biochemistry 1975; 14: 3229–3233
  • Carrell R. W., Lehmann H., Hutchison H. E. Haemoglobin Köln (β98 ValineMethionine): An unstable protein causing inclusion-body anaemia. Nature 1966; 210: 915–916
  • Woodson R. D., Heywood J. D., Lenfant C. Oxygen transport in Hemoglobin San Francisco. Clin. Res. 1970; 18: 134
  • Ohba Y., Miyaji T., Shibata S. Identical substitution in Hb Ube-1 and Hb Köln. Nature New Biol. 1973; 243: 205–207
  • Gordon-Smith E. G., Dacie J. V., Blecher T. E., French E. A., Wiltshire B. G., Lehmann H. Haemoglobin Nottingham, β98 (FG5) ValGly: A new unstable haemoglobin producing severe haemolysis. Prod. Roy. Soc. Med. 1973; 66: 507–508
  • Gacon G., Wajcman H., Labie D. A new unstable hemoglobin mutated in β98 (FG5) ValAla: Hb Djelfa. FEBS Lett. 1975; 58: 238–240
  • Reed C. S., Hampson R., Gordon S., Jones R. T., Novy M. J., Brimhall B., Edwards M. J., Koler R. D. Erythrocytosis secondary to increased oxygen affinity of a mutant hemoglobin, Hemoglobin Kempsey. Blood 1968; 31: 623–632
  • Jones R. T., Osgood E. E., Brimhall B., Koler R. D. Hemoglobin Yakima: I. Clinical and biochemical studies. J. Clin. Invest. 1967; 46: 1840–1847
  • Weatherall D. J., Clegg J. B., Callender S. T., Wells R. M. G., Gale R. E., Huehns E. R., Perutz M. F., Viggiano G., Ho C. Haemoglobin Radcliffe (α2β2 99 (G1) Ala): A high oxygen-affinity variant causing familial polycythaemia. Br. J. Haematol. 1977; 35: 177–191
  • Rucknagel D. L., Glynn K. P., Smith J. R. Hemoglobin Ypsilanti characterized by increased oxygen affinity, abnormal polymerization and erythremia. Clin. Res. 1967; 15: 270
  • Lokich J. J., Mahoney C. W., Bunn H. F., Bruckheimer S. M., Ranney H. M. Hemoglobin Brigham (α2Aβ2 100 ProLeu). Hemoglobin variant associated with familial erythrocytosis. J. Clin. Invest. 1973; 52: 2060–2067
  • Jones R. T., Brimhall B., Gray G. Hemoglobin British Columbia [α2β2 101 (G3) GluLys]: A new variant with high oxygen affinity. Hemoglobin 1976; 1: 171–182
  • Adams J. B., Winter W. P., Tausk K., Heller P. Hemoglobin Rush [β-101 (G3) Glutamine]: A new unstable hemoglobin causing mild hemolytic anemia. Blood 1974; 45: 261–169
  • Mant M. J., Salkie M. L., Cope N., Appling F., Bolch K., Jayalakshmi M., Gravely M., Wilson J. B., Huisman T. H. J. Hb Alberta or α2β2 (101 (G3) GluGly), a new high-oxygen affinity hemoglobin variant causing erythrocytosis. Hemoglobin 1976–77; 1: 183–194
  • Charache S., Jacobson R., Brimhall B., Murphy E. A., Hathaway P., Winslow R., Jones R., Rath C., Simkovich J. Hb Potomac (β101 GluAsp): Speculations on placental oxygen transport in carriers of high-affinity hemoglobins. Blood 1978; 51: 331–338
  • Efremov G. D., Huisman T. H. J., Smith L. L., Wilson J. B., Kitchens J. L., Wrightstone R. N., Adams H. R. Hemoglobin Richmond, a human hemoglobin which forms asymmetric hybrids with other hemoglobins. J. Biol. Chem. 1969; 244: 6105–6116
  • Bonaventura J., Riggs A. Hemoglobin Kansas, a human hemoglobin with a neutral amino acid substitution and an abnormal oxygen equilibrium. J. Biol. Chem. 1968; 243: 980–991
  • Nagel R. L., Joshua L., Johnson J., Landau L., Bookchin R. M., Harris M. B. Hemoglobin Beth Israel: A mutant causing clinically apparent cyanosis. N. Engl. J. Med. 1976; 295: 125–130
  • White J. M., Szur L., Gillies I. D. S., Lorkin P. A., Lehmann H. Familial polycythaemia caused by a new haemoglobin variant. Hb Heathrow β103 (G5) PhenylalanineLeucine. Br. Med. J. 1973; 3: 665–667
  • Wilkinson T., Chua Ching Geh, Carrell R. W., Robin H., Exner T., Lee Kit Ming, Kronenberg H. A new haemoglobin variant, Haemoglobin Camperdown β104 (G6) ArginineSerine. Biochim. Biophys. Acta 1975; 393: 195–200
  • Ryrie D. R., Plowman D., Lehmann H. Haemoglobin Sherwood Forest β104 (G6) ArgThr. FEBS Lett. 1977; 83: 260–262
  • Hyde R. D., Hall M. D., Wiltshire B. G., Lehmann H. Haemoglobin Southampton, β106 (G8) LeuPro: An unstable variant producing severe haemolysis. Lancet 1972; 2: 1170–1172
  • Koler R. D., Jones R. T., Bigley R. H., Litt M., Lovrien E., Brooks R., Lahey M. E., Fowler R. Hemoglobin Casper: β106 (G8) LeuPro, a contemporary mutation. Am. J. Med. 1973; 55: 549–558
  • Kleihauer E., Waller H. D., Benohr H. C., Kohne E., Gelinsky P. Hb Tübingen, nine neue β-kettenvariante (Tp 10–12) mit erhähter spontanozydation. Klin. Wochenschr. 1971; 48: 651–659
  • Kohne E., Kley H. P., Kleihauer E., Versmold H., Benohr H. C., Braunitzer G. Structural and functional characteristics of the Hb Tubingen: β106 (G8) LeuGln. FEBS Lett. 1976; 64: 443–447
  • Turner J. W., Jr., Jones R. T., Brimhall B., Du Val M. C., Koler R. D. Characterization of Hemoglobin Burke [β107 (G9) GlyArg]. Biochem. Gen. 1976; 14: 577–585
  • Imamura T., Fujita S., Ohta Y., Hanada M., Yanese T. Hemoglobin Yoshizuka (G10(108) β AsparagineAspartic acid): A new variant with a reduced oxygen affinity from a Japanese family. J. Clin. Invest. 1969; 48: 2341–2348
  • Moo-Penn W. F., Wolff J. A., Simon G., Vacek M., Jun D. L., Johnson M. H. Hemoglobin Presbyterian: β108 (G10) AsparagineLysine. A hemoglobin variant with low oxygen affinity. FEBS Lett. 1978; 92: 53–56
  • Nute P. E., Stamatoyannopoulos G., Hermodson M. A., Roth D., Hornung S. Hemoglobinopathic erythrocytosis due to a new electrophoretically silent variant, Hemoglobin San Diego (β109 (G11) ValMet). J. Clin. Invest. 1974; 53: 320–328
  • King M. A. R., Wiltshire B. G., Lehmann H., Morimoto H. An unstable haemoglobin with reduced oxygen affinity: Haemoglobin Peterborough, β111 (G13) ValinePhenylalanine, its interaction with normal haemoglobin and with Haemoglobin Lepore. Br. J. Haematol. 1972; 22: 125–134
  • Adams J. G., Boxer L. A., Baehner R. L., Forget B. G., Tsistrokis G. A., Steinberg M. H. Hemoglobin Indianapolis (6112 [G14) Arginine): An unstable β-chain variant producing the phenotype of severe β-thalassemia. J. Clin. Invest. 1979; 63: 931–938
  • Ranney H. M., Jacots A. S., Nagel R. L. Haemoglobin New York. Nature 1967; 213: 876–878
  • Outeirino J., Casey R., White J. M., Lehmann H. Haemoglobin Madrid, β115 (G17) AlanineProline: An unstable variant associated with haemolytic anaemia. Acta Haematol. 1974; 52: 53–60
  • Schneider R. G., Alperin J. B., Brimhall B., Jones R. T. Hemoglobin P (α2β2 117 Arg): Structure and properties. J. Lab. Clin. Med. 1969; 73: 616–622
  • Schneider R. G., Berkman N. L., Brimhall B., Jones R. T. Hemoglobin Fannin-Lubbock [α2β2119 (GH2) GlyAsp]. A slightly unstable mutant. Biochim. Biophys. Acta 1976; 543: 478–483
  • Moo-Penn W. F., Bechtel K. C., Johnson M. H., Jue D. L., Therrell B. L., Jr., Morrison B. Y., Schmidt R. M. Hemoglobin Fannin-Lubbock [α2β2119 (GH2) GlyAsp]: A new hemoglobin variant at the α1β1 contact. Biochim. Biophys. Acta 1976; 453: 472–477
  • Chen-Marotel J., Braconnier F., Blouquit Y., Martin-Caburi J., Kammerer J., Rosa J. Hemoglobin Bougardirey-Mali β119 (GH2) GlyVal. An electrophoretically silent variant migrating in isoelectrofocusing as Hb F. Hemoglobin 1979; 3: 253–262
  • Miyaji T., Ohba Y., Yamamoto K., Shibata S., Iuchi I., Hamilton H. B. Hemoglobin Hijiyama: A new fast-moving hemoglobin in a Japanese family. Science 1968; 159: 204–206
  • El-Hazmi M. A. F., Lehmann H. Hemoglobin Riyadh [α2β2 120 (GH3) LysAsn] - a new variant found in association with α-thalassemia and iron deficiency. Hemoglobin 1976; 1: 59–74
  • Miyaji T., Ohba Y., Matsuoka M., Kudoh H., Asano M., Yamamoto K., Satoh T. Hemoglobin Karatsu: Beta 120 (GH3) LysineAsparagine. An example of Hb Riyadh in Japan. Hemoglobin 1977; 1: 461–466
  • Baglioni C. Abnormal human haemoglobins. VIII. Chemical studies on Haemoglobin D. Biochim. Biophys. Acta 1962; 59: 437–449
  • Ozsoylo S. Homozygous Hemoglobin D Punjab. Acta Haematol. 1970; 42: 353–359
  • Ramot B., Rotem J., Rahbar S., Jacobs A. S., Uden L., Ranney H. M. Hemoglobin D Punjab in a Bulgarian Jewish family. Israel J. Med. Sci. 1969; 5: 1066–1070
  • Smith E. W., Conley C. L. Sickle cell-Hemoglobin D disease. Ann. Intern. Med. 1959; 50: 94–98
  • Wasi P., Pootrakul S., Na-Nakorn S., Beale D., Lehmann H. Haemoglobin D β Los Angeles (D Punjab, α2β2 125 GluNH2) in a Thai family. Acta Haematol. 1968; 39: 151–158
  • Imamura T., Riggs A. Identification of Hemoglobin Oak Ridge with Hemoglobin D Punjab (Los Angeles). Biochem. Genet. 1972; 7: 127–130
  • Bowman B., Ingram V. M. Abnormal human haemoglobins. VII. The comparison of normal human Haemoglobin D Chicago. Biochim. Biophys. Acta 1961; 53: 569–573
  • Baglioni C., Lehmann H. Chemical heterogeneity of Haemoglobin O. Nature 1962; 196: 229–232
  • Kamel K., Hoerman K., Awny A. Ethnological significance of hemoglobin α2β2 121 Lys. Am. J. Phys. Anthropol. 1970; 26: 107–108
  • Efremov G. D., Duma H., Rudivic R., Rolovic Z., Wilson J. B., Huisman T. H. J. Hemoglobin Beograd or α2β2 121 GluVal (GH4). Biochim. Biophys. Acta 1973; 328: 81–83
  • Clegg J. B., Weatherall D. J., Boon Wong Hock, Mustafa D. Two new haemoglobin variants involving proline substitutions. Nature 1969; 22: 379–380
  • Bursaux E., Blouquit Y., Poyar C., Rosa J., Arous N., Bohn B. Hemoglobin Ty Gard (α2Aβ2 124 (H2) ProGln): A stable high O2 affinity variant at the α1β1 contact. FEBS Lett. 1978; 88: 155–159
  • Miyaji T., Ohba Y., Yamamoto K., Shibata S., Iuchi I., Takenaka H. Japanese haemoglobin variant. Nature 1968; 217: 89–90
  • Altay C., Altinoz N., Wilson J. B., Bolch K. C., Huisman T. H. J. Hemoglobin Hacettepe or α2β2 127 (H5) GlnGlu. Biochim. Biophys. Acta 1976; 434: 1–3
  • Martinez G., Lima F., Colombo B. Haemoglobin J Guantanamo (α2β2 128 (H6) AlaAsp). A new fast unstable haemoglobin found in a Cuban family. Biochim. Biophys. Acta 1977; 491: 1–6
  • Blackwell R. Q., Yang Y.-J., Wang C.-C. Hemoglobin J Taichung: β129 AlaAsp. Biochim. Biophys. Acta 1969; 194: 1–5
  • Maniatis A., Bousios T., Nagel R. L., Balazs T., Ueda Y., Bookchin R. M., Maniatis G. M. Hemoglobin Crete (β129 AlaPro): A new high-affinity variant interacting with (β0- and δβ0-thalassemia. Blood 1979; 54: 54–63
  • Lorkin P. A., Pietschmann H., Braunsteiner H., Lehmann H. Structure of Haemoglobin Wien β130 (H8) TyrosineAspartic acid: An unstable haemoglobin variant. Acta Haematol. 1974; 51: 351–361
  • Wade Cohen P. T., Yates A., Bellingham A. J., Huehns E. R. Amino acid substitution on the α1β1 intersubunit contact of Haemoglobin Camden β131 (H9) GlnGlu. Nature New Biol. 1973; 243: 467–468
  • Ohba Y., Miyaji T., Matsuoka M., Ueda S., Iuchi I., Shibata S. Hemoglobin Tokuchi: β131 GlutamineGiutamic acid, an example of Hb Camden in Japan. Acta Haematol. Jap. 1975; 38: 1–7
  • Brennan S. O., Arnold B., Fleming P., Carrell R. W. A new unstable haemoglobin, β134 ValGlu. Proc. New Zealand Med. J. 1977; 85: 398
  • Arends T., Lehmann H., Plowman D., Stathopoulou R. Hemoglobin North Shore–Caracas β134 (H12) ValineGlutamic acid. FEBS Lett. 1977; 80: 261–265
  • Marti H. R., Winterhalter K. H., Di lorio E. E., Lorkin P. A., Lehmann H. Hb Altdorf α2β2 135 (H13) AlaPro: A new electrophoretically silent unstable haemoglobin variant from Switzerland. FEBS Lett. 1976; 63: 193–196
  • Minnich V., Hill R. J., Khuri P. D., Anderson M. E. Hemoglobin Hope: A beta chain variant. Blood 1965; 25: 830–838
  • Tentori L., Carti Sorcini M., Bucella C. Hemoglobin Abruzzo: Beta 143 (H21) His-Arg. Clin. Chim. Acta 1972; 38: 258–262
  • Bromberg P. A., Alben J. O., Bare G. H., Balcerzak S. P., Jones R. T., Brimhall B., Padilla F. Hemoglobin Little Rock (β143 HisGln: (H21)). A high oxygen affinity haemoglobin variant with unique properties. Nature New Biol. 1973; 243: 177–179
  • Jensen M., Oski F. A., Nathan D. G., Bunn H. F. Hemoglobin Syracuse (α2β2 143 (H21) HisPro), a new high-affinity variant detected by special electrophoretic methods. J. CLin. Invest. 1975; 55: 469–477
  • Zak S. J., Brimhall B., Jones R. T., Kaplan M. E. Hemoglobin Andrew-Minneapolis α2A62 144 LysAsn: A new high-oxygen affinity mutant human hemoglobin. Blood 1974; 44: 543–549
  • Hayashim A., Stamatoyannopoulos G., Yoshida A., Adamson J. Haemoglobin Rainier: β145 (HC2) Tyrosine-Cysteine and Haemoglobin Bethesda: β145 (HC2) TyrosineHistidine. Nature New Biol. 1971; 230: 264–267
  • Kleckner H. B., Wilson J. B., Lindeman J. G., Stevens P. D., Niazi G., Hunter E., Chen C. J., Huisman T. H. J. Hemoglobin Fort Gordon or α2β2 145 TyrAsp, a new high-oxygen affinity hemoglobin variant. Biochim. Biophys. Acta 1975; 400: 343–347
  • Charache S., Brimhall B., Jones R. T. Polycythemia produced by Hemoglobin Osier (β145 (HC2) TyrAsp). Johns Hopkins Med. J. 1975; 136: 132–136
  • Gacon G., Wajcman H., Labie D. Structural and functional study of Hb Nancy β145 (HC2) TyrAsp: A high oxygen affinity hemoglobin. FEBS Lett. 1975; 56: 39–42
  • Winslow R. M., Swenberg M.-L., Gross E., Chervenick P. A., Buchman R. R., Anderson W. F. Hemoglobin McKees Rocks (α2β2 145 TyrTerm): A human “nonsense” mutation leading to a shortened β-chain. J. Clin. Invest. 1976; 57: 772–781
  • Imai K. Oxygen-equilibrium characteristics of abnormal Hemoglobin Hiroshima (α2β2 143 Asp). Arch. Biochem. Biophys. 1968; 127: 543–547
  • Barem G. H., Bromberg P. A., Alben J. O., Brimhall B., Jones R. T., Mintz S., Rother I. Altered C-terminal salt bridges in Haemoglobin York cause high oxygen affinity. Nature 1976; 259: 155–156
  • Wajcman H., Kilmartin J. V., Najman A., Labie D. Hemoglobin Cochin-Port Royal – consequences of the replacement of the β chain C-terminal by an arginine. Biochim. Biophys. Acta 1975; 400: 354–364
  • Jones R. T., Brimhall B., Huehns E. R., Barnicot N. A. Hemoglobin Sphakia: A delta chain variant of Hemoglobin A2 from Crete. Science 1966; 151: 1406–1408
  • Ranney H. M., Jacobs A. S., Ramot B., Bradley T. B., Jr. Hemoglobin NYU, a delta chain variant, α2δ2 12 Lys. J. Clin. Invest. 1969; 48: 2057–2062
  • Ball E. W., Meynell M. J., Beale D., Kynoch P., Lehmann H., Stretton A. O. W. Haemoglobin A21: α2β2 16 GlycineArginine. Nature 1966; 209: 1217–1218
  • Rieder R. F., Clegg J. B., Weiss H. J., Christy N. P., Rabinowitz R. Hemoglobin A2-Roosevelt: α2β2 20 ValGlu. Biochim. Biophys. Acta 1976; 439: 501–504
  • Jones R. T., Brimhall B. Structural characterization of two δ chain variants. J. Biol. Chem. 1967; 21(12)5141–5145
  • Sharma R. S., Harding D. L., Wong S. C., Wilson J. B., Gravely M. E., Huisman T. H. J. A new δ chain variant Haemoglobin A2-Melbourne or or α2β2 43 GluLys (CD2). Biochim. Biophys. Acta 1974; 359: 233–235
  • XIII Meeting Gruppo di Studio Dell'Entrocita, Torino 12. June, 1977
  • Lie-Injo L. E., Pribada W., Boerma F. W., Efremov G. D., Wilson J. B., Reynolds C. A., Huisman T. H. J. Hemoglobin A2-Indonesia or α2δ2 β9 (E13) GlyArg. Biochim. Biophys. Acta 1971; 229: 335–342
  • Sharma R. S., Williams L., Wilson J. B., Huisman T. H. J. Hemoglobin A2-Coburg or α2δ2 116 ArgoHis (G18). Biochim. Biophys. Acta 1975; 393: 379–382
  • DeJong W. W. W., Bernini L. F. Haemoglobin Babinga (β136 GlycineAspartic acid): A new delta chain variant. Nature 1968; 219: 1360–1362
  • Lie-Injo L. E., Kamuzora H., Lehmann H. Haemoglobin F Malaysia: α2γ2 1 (NA1) Glycinecysteine: 136 Glycine. J. Med. Genet. 1974; 11: 25–30
  • Jenkins G. C., Beale D., Black A. J., Huntsman G. R., Lehmann H. Haemoglobin F Texas I (α2y2 5 GluLys): A variant of Haemoglobin F. Br. J. Haematol. 1967; 13: 252–255
  • Ahern E. J., Wiltshire B. G., Lehmann H. Further characterization of Haemoglobin F. Texas I γ5 Glutamic acidLysine: γ136 Alanine. Biochim. Biophys. Acta 1972; 271: 61–64
  • Larkin I. L. M., Baker T., Lorkin P. A., Lehmann H., Black A. J., Huntsman R. G. Haemoglobin F Texas 11 (α2γ2 6 GluLys). The second of the Haemoglobin F Texas variants. Br. J. Haematol. 1968; 14: 233–238
  • Carrell R. W., Owen M. C., Anderson R., Berry E. Haemoglobin F Auckland Gy7 AspAsn – further evidence for multiple genes for the gamma chain. Biochim. Biophys. Acta 1974; 365: 323–327
  • Loukopoulos D., Kaltsoya A., Fessas Ph. On the chemical abnormality of Hb “Alexandra” a fetal hemoglobin variant. Blood 1969; 33: 114–118
  • Brennan S. O., Smith Merran B., Carrell R. W. Haemoglobin F Melbourne Cγ16 GlyArg and Haemoglobin F Carlton Gγ121 GluLys. Biochim. Biophys. Acta 1977; 490: 452–455
  • Lie-Injo L. E., Wiltshire B. G., Lehmann H. Structural identification of Haemoglobin F Kuala Lumpur (α2γ2 22 (B4) AspGly: (136 Ala). Biochim. Biophys. Acta 1973; 322: 224–230
  • Ahern E. J., Jones R. T., Brimhall B., Gray R. H. Haemoglobin F Jamaica (α2β2 61 LysGlu: 136 Ala). Br. J. Haematol. 1970; 18: 369–375
  • Ahern E., Holder W., Ahern V., Serjeant G. R., Serjeant S. E., Forbes M., Brimhall B., Jones R. T. Haemoglobin F Victoria Jubilee (α2Aγ2 80 AspTyr). Biochim. Biophys. Acta 1975; 393: 188–194
  • Schneider R. G., Haggard M. E., Gustavson L. P., Brimhall B., Jones R. T. Genetic haemoglobin abnormalities in about 9,000 Black and 7,000 White newborns: Haemoglobin F Dickinson (A97 HisArg), a new variant. Br. J. Haematol. 1974; 28: 515–524
  • Omura H., Miyaji T., Shibata S. Hemoglobin F Ube (108 AsnLys), a new abnormal fetal hemoglobin found in a Japanese baby. Chem. Abstr. 1975; 83: 266
  • Cauchi M. N., Clegg J. B., Weatherall D. J. Haemoglobin F (Malta) a new foetal haemoglobin variant with a high incidence in Maltese infants. Nature 1969; 223: 311–313
  • Sacker L. S., Beale D., Black A. J., Huntsman R. G., Lehmann H., Lorkin P. A. Haemoglobin F Hull (γ121 Glutamic acidLysine), homologous with Haemoglobins O and O Indoneisa. Br. Med. J. 1961; 3: 531–533
  • Brimhall B., Vedvick T. S., Jones R. T., Ahern E., Palomino E., Ahern V. Haemoglobin F Port Royal (α2Gγ 125 GluAla). Br. J. Haematol. 1973; 27: 313–320
  • Lee-Potter J. P., Deacon-Smith R. A., Simpkiss M. J., Kamuzora H., Lehmann H. A new cause of haemolytic anemia in the newborn. A description of an unstable fetal haemoglobin: F Poole, α2Gγ2 130 Tryptophan Glycine. J. Clin. Pathol. 1975; 28: 317–320
  • Barnabas J., Muller C. J. Haemoglobin Lepore Hollandia. Nature 1962; 194: 931–932
  • Ostertag W., Smith E. W. Hemoglobin-Lepore Baltimore, a third type of a δβ crossover (δ50, β86). Eur. J. Biochem. 1969; 10: 371–376
  • Baglioni C. The fusion of two peptide chains in Hemoglobin Lepore and its interpretation as a genetic deletion. Proc. Natl. Acad. Sci. USA 1962; 48: 1880–1886
  • Ohta Y., Yamaoka K., Sumida I., Yanase T. Hemoglobin Miyada, a β-δ fusion peptide (anti-Lepore) type discovered in a Japanese family. Nature New Biol. 1971; 234: 218–219
  • Lehmann H., Charlesworth D. Observation on Haemoglobin P (Congo type). Biochem. J. 1970; 119: 43
  • Badr F. M., Lorkin P. A., Lehmann H. Haemoglobin P-Nilotic: containing a β-δ chain. Nature New Biol. 1973; 242: 107–110
  • Huisman T. H. J., Wrightstone R. N., Wilson J. B., Schroeder W. A., Kendall A. G. Hemoglobin Kenya, the product of fusion of γ and β polypeptide chains. Arch. Biochem. Biophys. 1972; 153: 850–853
  • Milner P. F., Clegg J. B., Weatherall D. J. Haemoglobin H disease due to a unique hemoglobin variant with an elongated α-chain. Lancet April 10, 1971; 729–732
  • Weatherall D. J., Clegg J. B. The α-chain-termination mutants and their relation to the α-thalassemias. Phil. Trans. Roy. Soc. 1975; B127: 411–455
  • Clegg J. B., Weatherall D. J., Contopolou-Griva I., Caroutsos K., Poungouras P., Tsevrenis H. Haemoglobin Icaria, a new chain-termination mutant which causes α thalassemia. Nature 1974; 251: 245–247
  • DeJong W. W. W., Meera Khan P., Bernini L. F. Hemoglobin Koya Dora: High frequency of a chain termination mutant. Am. J. Hum. Genet. 1975; 27: 81–90
  • Flatz G., Kinderlerer J. L., Kilmartin J. V., Lehmann H. Haemoglobin Tak: A variant with additional residues at the end of the β-chains. Lancet 1971; 10: 732–733
  • Imai K., Lehmann H. The oxygen affinity of Haemoglobin Tak, a variant with an elongated β chain. Biochim. Biophys. Acta 1975; 412: 288–294
  • Lehmann H., Casey R., Lang A., Stathopoulou R., Imai K., Chinda S., Vinai P., Flatz G. Haemoglobin Tak: A β-chain elongation. Br. J. Haematol. 1975; 31: 119–131, Suppl
  • Seid-Akhaven M., Winter W. P., Abramson R. K., Rucknagel D. L. Hemoglobin Wayne: A frameshift mutation detected in human hemoglobin alpha chains. Proc. Natl. Acad. Sci., USA 1976; 73: 882–886
  • Bunn H. F., Schmidt G. J., Haney D. N., Dluhy R. G. Hemoglobin Cranston, an unstable variant having an elongated β chain due to a non-homologous crossover between two normal β chain genes. Proc. Natl. Acad. Sci. USA 1975; 72: 3609–3613
  • Huisman T. H. J., Wilson J. B., Gravely M., Hubbard M. Hemoglobin Grady: The first example of a variant with elongated chains due to an insertion of residues. Proc. Natl. Acad. Scl. USA 1974; 71: 3270–3273
  • Scott A. F., Phillips J. A., III, Young K. E., Kazazian H. H., Jr., Smith K. D., Charache S., Clegg J. B. The molecular basis of Hemoglobin Grady. Am. J. Hum. Genet. 1981; 33: 129–133
  • Garel M. C., Goossens M., Oudart J. L., Blouquit Y., Thillet J., Rosa J. Hemoglobin Dakar = Hemoglobin Grady: Demonstration by a new approach to the analysis of the tryptic core region of the α chain and oxygen equilibrium properties. Biochim. Biophys. Acta 1976; 453: 459–471
  • DeJong W. W. W., Went L. N., Bernini L. F. Haemoglobin Leiden: Deletion of β6 or 7 glutamic acid. Nature 1968; 220: 788–790
  • Cohen-Solal M., Blouquit Y., Garel M. C., Thillet J., Gaillard L., Creyssel R., Gibaud A., Rosa J. Haemoglobin Lyon (β17–18 (A14–15) Lys-Val0) determination of sequenator analysis. Biochim. Biophys. Acta 1974; 351: 306–316
  • Jones R. T., Brimhall B., Huisman T. H. J., Kleihauer E., Betke K. Hemoglobin Freiburg: Abnormal hemoglobin due to deletion of a single amino acid residue. Science 1966; 154: 1024–1027
  • Praxedes H., Lehmann H. Haemoglobin Niteroi – a new unstable variant. Proc. 14th International Congress of Hematology, Sao PauloBrazil, 1972
  • Shibata S., Miyaji T., Ueda S., Matsuoka M., Iuchi I., Yamada K., Shinkai N. Hemoglobin Tochigi (beta 56–59 deleted). A new unstable hemoglobin discovered in a Japanese family. Proc. Jap. Acad. 1970; 46: 440–445
  • Wajcman H., Labie D., Schapira G. Two new hemoglobin variants with deletion. Hemoglobin Tours: Thr β87 (F3) deleted and Hemoglobin St. Antoine: GlyLeu β74–75 (E18–19) deleted. Consequences for oxygen affinity and protein stability. Biochim. Biophys. Acta 1973; 295: 495–504
  • Bradley T. B., Wohl R. C., Rieder R. F. Hemoglobin Gun Hill: Deletion of five amino acid residues and impaired heme–globin binding. Science 1967; 157: 1581–1583
  • Lutcher C. L., Huisman T. H. J. Hb-Leslie, an unstable variant due to deletion of Gin β131, occurring in combination with β-thalassemia, Hb-S, and Hb-C. Clin. Res. 1975; 23: 278A
  • Lutcher C. L., Wilson J. B., Gravely M. E., Stevens P. D., Chen C. J., Linderman J. G., Wong S. C., Miller A., Gottleib M., Huisman T. H. J. Hb Leslie, an unstable hemoglobin due to deletion of glutaminyl residue β131 (H9) occurring in association with β-thalassemia, Hb-C, and Hb-S. Blood 1976; 47: 99–112
  • Moo-Penn W. F., Jue D. L., Bechtel K. C., Johnson M. H., Bemis E., Brosious E., Schmidt R. M. Hemoglobin Deaconess, a new deletion mutant: β131 (H9) Glutamine deleted. Biochem. Biophys. Res. Commun. 1975; 65: 8–15
  • Casey R., Kynoch P. A. M., Lang A., Lehmann H., Nozari G., Shinton N. K. Double heterozygosity for two unstable haemoglobins: Hb Sydney (β67 [E11] ValAla) and Hb Coventry (β141 [H19] LeuDeleted). Brit. J. Haematol. 1978; 38: 195–209
  • Bookchin R. M., Nagel R. L., Ranney H. M. Structure and properties of Hemoglobin C Harlem, a human hemoglobin variant with amino acid substitutions in 2 residues of the β-polypeptide chain. J. Biol. Chem. 1967; 242: 248–255
  • Lang A., Lehmann H., McCurdy P. R., Pierce L. Identification of Haemoglobin C Georgetown. Biochim. Biophys. Acta 1972; 278: 57–61
  • Adams J. G., Heller P. Hemoglobin Arlington Park: a new hemoglobin variant with two amino acid substitutions in the β chain. Hemoglobin 1977; 1: 419–426
  • Blackwell R. Q., Boon Wong Hock, Liu C.-S., Weng M. I. Hemoglobin J Singapore: α78 AsnAsp: α79 AlaGly. Biochim. Biophys. Acta 1972; 278: 482–490
  • Goossens M., Garel M. C., Auvinet J., Basset P., Gomes P. F., Rosa J. Hemoglobin C Ziguinchor α2Aβ2 6 (A3) GluVal β58 (E2) ProArg: The second sickling variant with amino acid substitutions in 2 residues of the β polypeptide chain. FEBS Lett. 1975; 58: 149–154
  • Moo-Penn W. F., Schmidt R. M., Jue D. L., Bechtel K. C., Wright J. M., Horne M. K., III, Haycraft C. L., Roth E. F., Nagel R. L. Hemoglobin S Travis. A sickling hemoglobin with two amino acid substitutions [β6 (A3) Glutamic acidValine and β142 (H20) AlanineValine). Eur. J. Biochem. 1977; 77: 561–566
  • Marinucci M., Mavilio F., Massa A., Gabbianelli M., Fontanarosa P. P., Camagna A., Ignesti C., Tentori L. A new abnormal human hemoglobin: Hb Prato (α2 31 (B12) ArgSer β2). Biochem. Biophys. Acta 1979; 578: 534–540
  • Abramov A., Lehmann H., Robb L. Hb Shaare Zedek (α56 E5 LysGlu). FEBS Lett. 1980; 113: 235–237
  • Adams J. G., III, Steinberg M. H., Newman M. V., Morrison W. T., Benz E. J., Jr., Lyer R. β-Thalassemia present in cis to a new β-chain structural variant, Hb Vicksburg [β75 (E19) LeuO]. Proc. Natl. Acad. Sci. USA 1981; 78: 469–473
  • Wajcman H., Elion J., Boissel J. P., Labie D., Jos J., Girot R. A silent hemoglobin variant: Hemoglobin Necker Enfants-Malades (α20 (B1) HisTyr. Hemoglobin 1980; 4: 177–184
  • Tatsis B. Hemoglobin Queens (α34 (B15) LeuArg): A new variant at the α1β1 contact. Blood 1979; 54(suppl. 1)61a
  • Honig G. R., Vida L. N., Shamsuddin M., Mason R. G., Schlumpf H. W., Luke R. A. Hemoglobin Milledgeville (α44 (CD2) ProLeu) a new variant with increased oxygen affinity. Biochim. Biophys. Acta 1980; 626: 424–431
  • Szelenyi J. G., Horanyi M., Foldi J., Hudacsek J., Istvan L., Hollan S. R. A new hemoglobin variant in Hungary: Hb Savaria - α49 (CE7) SerMrg. Hemoglobin 1980; 4: 27–38
  • Nakatsuji T., Miwa S., Ohba Y., Miyaji T., Matsumoto N., Matsuoka I. Hemoglobin Tottori (α59 [E8] GlycineValine) a new unstable hemoglobin. Hemoglobin 1981; 5: 427–439
  • Spivak V. A., Moichanova T. P., Ermakov N. V., Tokarev Y. N., Martinez G., Szelenyi J., Horanyi M., Foldi J., Hollan S., Kazieva H., Shamov I. A. A new hemoglobin variant: Hb Dagestan β60 (E9) LysGlu. Hemoglobin 1981; 5: 133–138
  • Djoumessi S., Rousseaux J., Descamps J., Goudemand M., Dautrevaux M. Hemoglobin Lille, α2 [74 (EF3) AspAla] β2. Hemoglobin 1981; 5: 475–479
  • Liang C.-C., Chen S.-S., Jia P.-C., Wang L.-F., Luo H.-Y., Liu G.-Y., Liang S., Lung G.-F., Yu C.-M., Zhuang L.-Z., Liang B.-L., Tang Z.-N. Hemoglobin Duan, α75 (EF4) AspAla, a new variant found in China. Hemoglobin 1981; 5: 481–486
  • Iuchi I., Shimasaki S., Hidaka K., Harano T., Ueda S., Shibata S., Mizushima J., Kubo N. Hemoglobin Mizushi (α75 [EF4] AspGly): A new hemoglobin variant observed in a Japanese family. Hemoglobin 1980; 4: 209–214
  • Shibata S., Ueda S., Miyaji T., Imamura T. Hemoglobinopathies in Japan. Hemoglobin 1981; 5: 509–515
  • Benesch R., Personal Communication
  • Ohba Y., Miyaji T., Hattori Y., Fuyuno K., Matsuoka M. Unstable hemoglobins in Japan. Hemoglobin 1980; 4: 307–312
  • Honig G. R., Shamsuddin M., Zaizov R., Steinherz M., Solar I., Kirschmann C. Hemoglobin Petah Tikva (α110 AlaAsp): A new unstable variant with α-thalassemia-like expression. Blood 1981; 57: 705–711
  • Schneider R. G., Hightower B., Carpentieri U., Duerst M. L., Shih T. B., Jones R. T. Hemoglobin Oleander [α2 116 (GH4) GluGln β2]: Structural and functional characterization. Hemoglobin 1980; 6: 465–480
  • Fleming P. J., Hughes W. G., Farmilo R. K., Wyatt K., Cooper V. N. Hemoglobin Westmead α2 122 (H5) HisGln β2: A new hemoglobin variant with the substitution in the α1β1 contact area. Hemoglobin 1980; 4: 39–52
  • Harano T., Harano K., Ueda S., Shibata S., Iuchi I. Hemoglobin Yusa (β21 (B3) AspTyr), a new abnormal hemoglobin found in Japan. Hemoglobin 1981; 5: 121–131
  • Moo-Penn W. F., McPhedran P., Bobrow S., Johnson M. H., Jue D. L., Olsen K. W. Hemoglobin Connecticut (β21 (B3) AspGly): A hemoglobin variant with low oxygen affinity. Amer. J. Hemat. 1981; 11: 137–145
  • Shibata S., Miyaji T., Ohba Y. Abnormal hemoglobins in Japan. Hemoglobin 1980; 4: 395–408
  • Blouquit Y., Braconnier F., Cohen-Solal M., Foldi J., Arous N., Ankri A., Binet J. L., Rosa J. Hemoglobin Pitie-Salpetriere β34 (B16) ValPhe a new high oxygen affinity variant associated with familial erythrocytosis. Biochim. Biophys. Acta 1980; 624: 473–478
  • Wilkinson T., Brennan S. O., Carrell R. W., Wells R. M., Como P., Kronenberg H. Hemoglobin Summer Hill β52 (D3) AspHis a new variant from Sydney, Australia. Hemoglobin 1980; 4: 185–193
  • Marinucci M., Giuliani A., Maffi D., Massa A., Giampaolo A., Mavilio F., Zannotti M., Tentori L. Hemoglobin Bologna (α2β2 61 (E5) LysMet) an abnormal human hemoglobin with low oxygen affinity. Biochim. Biophys. Acta 1981; 668: 209–215
  • Brennan S. O., Wells R. M., Smith H., Carrell R. W. Hemoglobin Brisbane: β68 LeuHis. A new high oxygen affinity variant. Hemoglobin 1981; 5: 325–335
  • Johnson C. S., Moyes D., Schroeder W. A., Shelton J. B., Shelton J. R., Beutler E. Hemoglobin Pasadena, α2β2 75 (E19) LeuArg: Identification by high performance liquid chromatography of a new unstable variant with increased oxygen affinity. Biochim. Biophys. Acta 1980; 623: 360–367
  • Johnson M. H., Jue D. L., Patchen L. C., Hartwig E. C., Jr., Schneider N. J., Moo-Penn W. F. Hemoglobin Tampa: β79 (EF3) Aspartic acidTyrosine. Biochim. Biophys. Acta 1980; 623: 119–123
  • Blouquit Y., Braconnier F., Galacteros F., Arous N., Soria J., Zittoun R., Rosa J. Hemoglobin Hotel-Dieu β99 AspGly (G1). A new abnormal hemoglobin with high oxygen affinity. Hemoglobin 1981; 5: 19–31
  • Iuchi I., Hidaka K., Harano T., Ueda S., Shibata S., Shimasaki S., Mizushima J., Kubo N., Miyake T., Uchida T. Hemoglobin Takamatsu (β120 (GH3) LysGln): A new abnormal hemoglobin detected in three unrelated families in the Takamatsu area of Shikoku. Hemoglobin 1980; 4: 165–176
  • Moo-Penn W. F., Jue D. L., Johnson M. H., Bechtel K. C., Patchen L. C. Hemoglobin variants and methods used for their characterization during 7 years of screening at the Center for Disease Control. Hemoglobin 1980; 4: 347–361
  • Moo-Penn W. F., Schneider R. G., Shih T.-B., Jones R. T., Govindarajan S., Govindarajan P. G., Patchen L. C. Hemoglobin Ohio (β142 AlaAsp): A new abnormal hemoglobin with high oxygen affinity and erythrocytosis. Blood 1980; 56: 246–250
  • Hirano M., Ohba Y., Imai K., Ino T., Morishita Y., Matsui T., Shimizu S., Sumi H., Yamamoto K., Miyaji T. Hb Toyoake: β142 (H20) AlaPro. A new unstable hemoglobin with high oxygen affinity. Blood 1981; 57: 697–704
  • Schneider R. G., Bremner J. E., Brimhall B., Jones R. T., Shih T.-B. Hemoglobin Cowtown (β146 HC3 HisLeu). A mutant with high oxygen affinity and erythrocytosis. Amer. J. Clin. Pathol. 1979; 72: 1028–1032
  • Hayashi A., Fujita T., Fujimura M., Titani K. A new abnormal fetal hemoglobin, Hb FM-Osaka (α2γ2 63 HisTyr). Hemoglobin 1980; 4: 447–448
  • Fuyuno K., Torigoe T., Ohba Y., Matsuoka M., Miyaji T. Survey of cord blood hemoglobin in Japan and identification of two new γ chain variants. Hemoglobin 1981; 5: 139–151
  • Adams J. G., III, Morrison W. T., Steinberg M. H. Hemoglobin Parchman: double crossover within a single human gene. Science 1982; 218: 291–293
  • Honig G. R., Shamsuddin M., Mason R. G., Vida L. N. Hemoglobin Lincoln Park: A δβ fusion (anti-Lepore) variant with an amino acid deletion in the δ chain-derived segment. Proc. Nat. Acad. Sci. 1978; 75: 1475–1479
  • Rahbar S., Winkler K., Louis J., Rea C., Blume K., Beutler E. Hemoglobin Great Lakes (β68 [E12] LeucineHistidine): A new high-affinity hemoglobin. Blood 1981; 58: 813–817
  • Lee-Potter J. P., Deacon-Smith R. A., Lehmann H., Robb L. Haemoglobin Ferndown (α6 (A4] Aspartic acidValine). FEBS Lett. 1981; 126: 117–119
  • Zang Y.-T., Huang S.-Z., Liang X., Long G.-F., Lam H., Wilson J. B., Huisman T. H. J. Hb Wuming or α2 11 (A9) LysGln β2. Hemoglobin 1981; 5: 679–687
  • Liang C., Tao H., Lo H., Huang S., Li R., Wang B. Hemoglobin Shuangfeng (α27 (B8) GluLys): A new unstable hemoglobin variant. Hemoglobin 1981; 5: 691–700
  • Harano T., Harano K., Ueda S., Shibata S., Imai K., Ohba Y., Shinohara T., Florio S., Nishioka K., Shirotani H. Hemoglobin Kawachi [α44 (CE2) ProArg]: A new hemoglobin variant of high oxygen affinity with amino acid substitution at α1β2 contact. Hemoglobin 1982; 6: 43–49
  • Harano T., Harano K., Shibata S., Ueda S., Imai K., Saki M. Hb Handa [α90 (FG2) LysMet]: Structure and biosynthesis of a new slightly higher oxygen affinity variant. Hemoglobin 1982; 6: 379–389
  • Goossens M., Lee K. Y., Liebhaber S. A., Kan Y. W. Globin structural mutant α125 LeuPro is a novel cause of-thalassaemia. Nature 1982; 296: 864–865
  • Djoumessi S., Rousseaux J., Dautrevaux M. Structural studies of a new hemoglobin: Hb J Lens, β13 (A10) AlaAsp. FEBS Lett. 1981; 136: 145–147
  • Boissel J. P., Wajcman H., Fabritius H., Cabannes R., Labie D. Application of high-performance liquid chromatography to abnormal hemoglobin studies. Characterization of hemoglobin D in Ivory Coast and description of a new variant Hb Cocody (beta 21 (B3) Asp leads to Asn). Biochim. Biophys. Acta 1981; 670: 203–206
  • Nakatsuji T., Miwa S., Ohba Y., Hattori Y., Miyaji T., Miyata H., Shinohara T., Hori T., Takayama J. Hemoglobin Miyashiro (β23 [B5] ValGly) an electrophoretically silent variant discovered by the isopropanol test. Hemoglobin 1981; 5: 653–666
  • Nakatsuji T., Miwa S., Ohba Y., Hattori Y., Miyaji T., Nino S., Matsumoto N. A new unstable hemoglobin, Hb Yokohama β31 (B13) LeuPro, causing hemolytic anemia. Hemoglobin 1981; 5: 667–678
  • Yeager A. M., Zinkham W. H., Jue D. L., Winslow R. M., Johnson M. H., McGuffey J. E., Moo-Penn W. F. Hemoglobin Cheverly: an unstable hemoglobin associated with mild anemia. Pediatr. Res. 1983; 17: 503–507
  • Spivak V. A., Molchanova T. P., Postnikov Y. V., Aseeva E. A., Lutsenko I. N., Tokarev Y. N. A new abnormal hemoglobin: Hb Mozhaisk β92 (F8) HisArg. Hemoglobin 1982; 6: 169–181
  • Wajcman H., Aguilar J. L., Bascompte I., Labie D., Poyart C., Bohn B. Structural and functional studies of Hemoglobin Barcelona (α2β2 94 Asp (FG1)-His). J. Mol. Biol. 1982; 156: 185–202
  • Arous N., Braconnier F., Thillet J., Blouquit Y., Galacteros F., Chevrier M., Bordahandy C., Rosa J. Hemoglobin Saint Mande β102 (G4) AsnTyr: A new low oxygen affinity variant. FEBS Lett. 1981; 126: 114–116
  • Gibb E. A. Increased subunit association of a new superstable variant Hemoglobin Motown. Clin. Res. 1981; 29: 795A
  • Ohta Y., Saito S., Fujita S., Wilson J. B., Lam H., Huisman T. H. J. Hb F-Meinohama or α2γ2 (5 GluGly; 75 IIe; 136 Gly). Hemoglobin 1981; 5: 565–570
  • Yoshinaka H., Ohba Y., Hattori Y., Matsuoka M., Miyaji T., Fuyuno K. A new γ chain variant, Hb F Kotobuki or AγI 6 (A3) GluGly. Hemoglobin 1982; 6: 37–42
  • Johnson C. S., Schroeder W. A., Shelton J. B., Shelton J. R. The first example of a deletion in the human a chain: Hemoglobin Boyle Heights or α2 6(A4) AspOβ2. Hemoglobin 1983; 7: 125–140
  • Sugihara J., Imamura T., Yamada H., Imoto T., Matsuo T., Sumida I., Yanase T. A new electrophoretic variant of Hemoglobin (Ogi) in which a leucine residue is replaced by an arginine residue at position 34 of the α-chain. Biochim. Biophys. Acta 1982; 701: 45–48
  • Ricco G., Mazza U., Turi R. M., Pich P. G., Camaschella C., Saglio G., Bernini L. F. Significance of a new type of human fetal hemoglobin carrying a replacement isoleucine threonine at position 75 (E19) of the γ chain. Hum. Genet. 1976; 32: 305–313
  • Webber B. B., Lam H., Wilson J. B., Huisman T. H. J. Hb Albany-Ga or α2 11 (A9) LysAsn β2. Hemoglobin 1963; 7: 257–262
  • Honig G. R., Shamsuddin M., Vida L. N., Mompoint M., Bowie L., Jones E., Well S. Hb Evanston (α14 TrpArg): A new variant with thalassemia-like hematologic expression. Blood 1982; 60(Suppl. 1)53a
  • Liang C.-C., Chen S., Yang K., Jia P., Ma Y., Li T., Ni X., Wang X., Deng Q., Yao S. Hemoglobin Beijing [α16 (A14) LysAsn): A new fast-moving hemoglobin variant. Hemoglobin 1982; 6(6)629–633
  • Sellaye M., Blouquit Y., Galacteros F., Arous N., Monplaisir N., Rhoda M. D., Braconnier F., Rosa J. A new silent hemoglobin variant in a Black family from French West Indies. Hemoglobin Le Lamentin α20 HisGln. FEBS Lett. 1983; 145(1)128–130
  • Zeng Y.-T., Huang S.-Z., Zhou X.-D., Qui X.-K., Dong Q.-Y., Li M.-Y., Bai J.-H. Hb Shenyang [α26 (B7) AlaGlu): A new unstable variant found in China. Hemoglobin 1982; 6: 625–628, (β)
  • Dysert P. A., II, Head C. G., Shih T. B., Jones R. T., Schneider R. G. Hb Dallas α2 97 (G4) AsnLys β2: A new abnormal hemoglobin with high oxygen affinity. Blood 1982; 60(Suppl. 1)53a
  • Harano T., Harano K., Shibata S., Ueda S., Imai K., Seki M. Hemoglobin Tokoname [α139 (HCI) LysThr]: A new hemoglobin variant with a slightly increased oxygen affinity. Hemoglobin 1983; 7(1)85–90
  • Harano T., Harano K., Ueda S., Shibata S., Imai K., Seki M. Hemoglobin Machida [β6 (A3) GluGln], a new abnormal hemoglobin discovered in a Japanese family: structure, function and biosynthesis. Hemoglobin 1982; 6(5)531–535
  • Moo-Penn W. F., Johnson M. H., McGuffey J. E., Jun D. L., Therrell B. L., Jr. Hemoglobin Rio Grande [68 (A5) LysThr], A new variant found in a Mexican-American family. Hemoglobin 1983; 7(1)91–95
  • Elion J., Wajcman H., Belkhodja-Dunda O., Lapoumeroulie C., Labie D., Messerschmitt J., Staal A. M., Desableno B. Hemoglobin J Amiens Beta 17 (A14) Lys replaced by Asn. Coincidence of a functionally silent new abnormal hemoglobin and a polycythemia vera. Nouv. Rev. Fr. Hematol. 1979; 21(4)347–352
  • Brennan S. O., Williamson D., Whisson M. E., Carrell R. W. Hemoglobin Palmerston North β23 (B5) ValPhe. A new variant identified in a patient with polycythemia. Hemoglobin 1982; 6(6)569–575
  • Arous N., Galacteros F., Fessas Ph., Loukopoulos D., Blouquit Y., Komis G., Sellaye M., Boussiou M., Rosa J. Structural study of hemoglobin Knossos, β27 (B9) AlaSer. A new abnormal hemoglobin present as a silent-thalassemia. FEBS Lett. 1982; 147: 247–250
  • Boissel J. P., Wajcman H., Labie D., Fabritius H., Cabannes R. Hb J Daloa [$57 (E1) AsnAsp): A new variant found in Ivory Coast. Hemoglobin 1982; 6(4)433–437
  • Como P. F., Kennett D., Wilkinson T., Kronenberg H. A new hemoglobin with high oxygen affinity Hemoglobin Bunbury: α2β2 [94 (FG1) AspAsn]. Hemoglobin 1983; 7: 413–421
  • Ohba Y., Hasegawa Y., Amino H., Miwa S., Nakatsuji T., Hattori Y., Miyaji T. Hemoglobin Saitama or β117 (G19) HisPro, a new variant causing hemolytic disease. Hemoglobin 1983; 7(1)47–56
  • Lu Y.-Q., Fan J.-L., Liu J.-F., Hu H.-L., Peng X.-H., Huang P.-Y., Chen S.-S., Jia P.-C., Yang K.-G., Liang C.-C., Ran X.-D., Zuo C.-R. Hemoglobin Jianghua [β120 (GH3) LysIIe): A new fast-moving variant found in China. Hemoglobin 1983; 7: 321–326
  • Yang K., Chen S., Jia P., Ma Y., Wu S., Liang C., Chen X., Zhang M., Tu Z., Gong S. Hemoglobin Jinan [β139 (H17) AsnAsp), a new abnormal hemoglobin found in China. Hemoglobin 1986; 10, In press
  • Salkie M. L., Gordon P. A., Rigal W. M., Lam H., Wilson J. B., Headlee M. E., Huisman T. H. J. Hb A2-Canada or α2δ2 99 (G1) AspAsn, a newly discovered delta chain variant with increased oxygen affinity occurring in cis to β-thalassemia. Hemoglobin 1982; 6(3)223–231
  • Juricic D., Crepinko I., Efremov G. D., Lam H., Webber B. B., Headlee M. G., Huisman T. H. J. Hb A2 Zagreb or α2δ2 125 (H3) GlnGlu in association with δβ-thalassemia in a Yugoslavian female. Hemoglobin 1983; 7: 443–448
  • Nakatsjui T., Webber B., Lam H., Wilson J. B., Huisman T. H. J., Sciarratta G. V., Sansone G., Molaro G. L. A new γ chain variant: Hb F-Pordenone [γ6 (A3) GluGln: 75 IIe: 136 Ala]. Hemoglobin 1982; 6(4)397–401
  • Nakatsuji T., Headlee M., Lam H., Wilson J. B., Huisman T. H. J. Hb F-Bonaire-Ga or α2β2 39 (C5) GlnArg, characterized by high pressure liquid chromatographic and microsequencing procedures. Hemoglobin 1982; 6(6)599–606
  • Honig G. R., Koshy M., Schroeder A., Shelton J. B., Shelton J. R. Hemoglobin F Lodz (Gγ 44 SerArg); a newly identified variant from an American infant of Polish descent. Biochim. Biophys. Acta 1982; 707: 213–216
  • Serjeant G. R., Serjeant B. E., Lehmann H., Dukes M., Robb L. Hb F Kingston [Gγ 55 (D6) MetArg]. FEBS Lett. 1982; 150(1)77–80
  • Nakatsuji T., Lam H., Huisman T. H. J. Hb F-Kennestone or α2Gγ2 (EF1) 77 HisArg observed in a Caucasian baby. Hemoglobin 1983; 7: 267–270
  • Nakatsuji T., Lam H., Carver J., Huisman T. H. J. Hb F-Marietta or GγI 80 [EF4] AspAsn, observed in a Caucasian baby. Hemoglobin 1982; 6(4)407–411
  • Nakatsuji T., Lam H., Wilson J. B., Weber B. B., Huisman T. H. J. Hb F-Columbus-Ga or α2Gγ2 94 (FG1) AspAsn. Hemoglobin 1982; 6(6)593–598
  • Shelton J. B., Shelton J. R., Espinueva Z., Huynh V., Schroeder W. A., Powars D. Hemoglobin F-Caltech: α2Gγ2 120 LysGln. Hemoglobin 1982; 6(6)577–592
  • Care A., Marinucci M., Massa A., Maffi D., Sposi N. M., Improta T., Tentori L. Hb F-Siena Iα2AγT2 121 (GH4) GlyLys]. A new fetal hemoglobin variant. Hemoglobin 1983; 7(1)79–83
  • Honig G. R. 1982, Personal Communication
  • Bradley T. B. 1982, Personal Communication
  • McDonald M. J., Noble R. W., Sharma V. S., Ranney H. M., Crookston J. H., Schwartz J. M. A comparison of the functional properties of two Lepore hemoglobins with those of Hemoglobin A1. J. Mol. Biol. 1975; 94: 305–310
  • Sugihara J., Imamura T., Kagimoto M., Matsuo T., Yamada H., Imoto T., Yanase T. A new electrophoretic variant of hemoglobin (Munakata) in which a lysine residue is replaced by a methionine residue at position 90 of the a chain. Biochim. Biophys. Acta 1983; 744: 119–120
  • Ohya Y. Abnormal hemoglobins in North-Kyushu Japan, with special reference to Hb-Kukura and Hb-Fukuoka. Jap. J. Human. Genet. 1963; 8: 23
  • Moo-Penn W. F., Bechtel K. C., Therrell B. L. Hemoglobin P Nilotic in a Mexican-American family. Hemoglobin 1978; 2: 65–69
  • Clegg J. B., Weatherall D. J., Milner P. F. Haemoglobin Constant Spring - a chain termination mutant. Nature 1971; 234: 337–340
  • Strahler J. R., Rosenbloom B. B., Hanash S. M. A silent, neutral substitution detected by reverse-phase high-performance liquid chromatography: Hemoglobin Beirut. Science 1983; 221: 860–862
  • Harano T., Harano K., Shibata S., Ueda S., Mori H., Arimasa N. Hemoglobin Okayama [β2 (NA2) HisGln]: a new ‘silent’ hemoglobin variant with substituted amino acid residue at the 2,3 diphosphoglycerate binding site. FEBS Lett. 1983; 156: 20–22
  • Wilkinson T., Gough P., Owen M. C., Carrell R. W., Kronenberg H. Detection of xariants of haemoglobin D in Australia: Hamoglobin D Camperdown α2Aβ2 121 GluVal and Haemoglobin D Punjab α2Aβ2 121 GluGln. Med. J. Aust. 1974; 2: 636–637
  • Blackwell R. Q., Liu C.-S., Wang C.-L. Hemoglobin New York in Chinese subjects in Taiwan. Amer. J. Physical Anthropology 1971; 34: 329–334
  • Wajcman H., Jones R. T. Proprietes fonctionelles des hemoglobines humaines mutees en position 673. Inserm 1977; 70: 269–276
  • Shimasaki S., Iuchi I., Hidaka K., Mizuta W. The survey of abnormal hemoglobin in Kobe district. Jap. J. Human Genet. 1983; 28: 127–128
  • Marinucci M., Boissel J. P., Massa A., Wajcman H., Tentori L., Labie D. Hemoglobin Maputo: a new β-chain variant (α2β2 47 (CD6) AspTyr) in combination with Hb S, identified by high performance liquid chromatography (HPLC). Hemoglobin 1983; 7: 423–433
  • Harano T., Harano K., Shibata S., Ueda S., Imai K., Tsuneshige A., Yamada H., Seki M., Fukui. Hemoglobin Kariya [α40 (C5) LysGlu] a new hemoglobin variant with an increased oxygen affinity. FEBS Lett. 1983; 153: 332–334
  • Kohne E., Behnken L. J., Leupold D., Rogge H., Martin H., Kleihaur E. Hemoglobin Presbyterian [β108 (G10) AsnLys] in a German family. Hemoglobin 1979; 3: 365–370
  • Como P. F., Barber S., Sage R. E., Kronenberg H. Hemoglobin Woodville: α6 (A4) Aspartic AcidTyrosine. Hemoglobin 1986; 10, in press
  • Sugihara J., Imamura T., Yamada H., Imoto T., Matsuo T., Sumida I., Yanase T. A new electrophoretic variant of hemoglobin (Ogi) in which a leucine residue is replaced by an arginine residue at position 34 of the α-chain. Biochim. Biophys. Acta 1982; 701: 45–48
  • Nakatsuji T., Wilson J. B., Huisman T. H. J. Hb Cordele α2 47 (CE5) Asp Ala β2 a mildly unstable variant observed in Black twins. Hemoglobin 1984; 8: 37–46
  • Wong S. C., Ali M. A. M., Pond J. R., Rubin S. M., Johnson S. E. N., Wilson J. B., Huisman T. H. J. Hb J-Singa (α-78 AsnAsp), a newly discovered hemoglobin variant with the same amino acid substitution as one of the two present in Hb J-Singapore (α-78 AsnAsp, α-79 AlaGly). Biochim. Biophys. Acta 1984; 784: 187–188
  • Sciarratta G. V., Ivaldi G., Parodi M. I., Sansone G., Molaro G. L., Salkie M. L., Wilson J. B., Reese A. L., Huisman T. H. J. The characterization of Hemoglobin Manitoba or α2102 (G9) SerArg β2 and Hemoglobin Contaldo or α2 103 (G10) HisArg β2 by high performance liquid chromatography. Hemoglobin 1984; 8: 169–181
  • Lin Cai Yin, He Be Wang, et al. A new fast-moving hemoglobin variant, Hb J Luhe β8 (A5) LysGln. Chinese Hematology Journal 1982; 3: 263–265
  • Wong S. C., Ali M. A. M., Lam H., Webber B. B., Wilson J. B., Huisman T. H. J. Hemoglobin Hamilton or α2β2 11 (A8) ValIIe, a silent β-chain variant detected by Triton X-100 acid-urea polyacrylamide gel electrophoresis. Am. J. Hematol. 1984; 16: 47–52
  • Williamson D., Brennan S. O., Muir H., Carrell R. W. Hemoglobin Collingwood β60 (E4) ValAla - a new unstable hemoglobin. Hemoglobin 1983; 7: 511–519
  • Jen P. C., Chen L. C., Chen P. F., Wong Y., Chen L. F., Guo Y. Y., Chang F. Q., Chow Y. C., Chiu Y. Hemoglobin Quin-Hai, β78 (EF2) LeuArg, a new abnormal hemoglobin found in Guangdong, China. Hemoglobin 1983; 7(5)407–412
  • Hedlund B., Paine S., Smith C. M., II, Raines J., Morrison W. T., Adams J., III. Hemoglobin Minneapolis-Laos [5–118 (GH1) PheTyr] a new hemoglobin variant with normal functional properties. Hemoglobin 1984; 8: 75–78
  • Brennan S. O., Williamson D., Smith M. B., Cauchi M. N., Macphee A., Carrell R. W. Hb A2 Victoria δ24 (B6) GlyAsp, a new δ chain variant occurring with β thalassemia. Hemoglobin 1984; 8: 163–168
  • Garcia C. R., Navarro J. L., Lam H., Webber B. B., Headlee M. G., Wilson J. B., Huisman T. H. J. Hb A2-Manzanares or α2β2 121 (GH4) GluVal, an unstable δ chain variant observed in a Spanish family. Hemoglobin 1983; 7: 435–442
  • Nakatsuji T., Lam H., Huisman T. H. J. Hb F-Calluna or α2γ2 (12 ThrArg; 75 IIe; 136 Ala) in a Caucasian baby. Hemoglobin 1983; 7: 563–566
  • Zen G., Huang S. Z., Nakatsuji T., Huisman T. H. J. GγAγ Thalassemia and γ-chain variants in Chinese newborn babies. Am. J. Hematol. 1985; 18: 235–242
  • Nakatsuji T., Shimizu K., Huisman T. H. J. Hb F-La Grange or α2γ2 101 (G3) GluLys; 75 IIe; 136 Gly; a high oxygen affinity fetal hemoglobin variant observed in a Caucasian newborn. Biochim. Biophys. Acta. 1984; 789: 224–228
  • Blouquit Y., Thillet J., Beuzard Y., Vernant J. P., Dreyfus B. Structural and functional studies of Hemoglobin J Calabria: β64 (E8) GlyAsp. Biochim. Biophys. Acta 1977; 492: 426–432
  • Moo-Penn W. F., Baine R. M., Jun D. L., Johnson M. H., McGuffey J. E., Benson J. M. Hemoglobin Evanston: α14 (A12) TrpArg, a variant hemoglobin associated with α-thalassemia-2. Biochim. Biophys. Acta 1983; 747: 65–70
  • Wada Y., Hayashi A., Masanori I., Katakuse T., Ichihara H., Nakabushi T., Matsuo T., Sakurai T., Matsuda H. Characterization of a new fetal hemoglobin variant, Hb F-Izumi Aγ6 GluGly, by molecular secondary Ion mass spectrometry. Biochim. Biophys. Acta 1983; 749: 244
  • Rochette J., Poyart C., Varet B., Wajcman H. A new hemoglobin variant altering the α1β2 contact: Hb Chemilly α2β2 99 (G1) AspVal. FEBS Lett. 1984; 166: 8–12
  • Rochette J., Varet B., Boissel J. P., Clough K., Lable D., Wajcman H., Bohn B., Magne P., Poyart C. Structure and function of Hb Saint-Jacques (α2β2 140 (H18) AlaThr): A new high-oxygen-affinity variant with altered bisphosphoglycerate binding. Biochim. Biophys. Acta 1984; 785: 14–21
  • Harano T., Harano K., Shibata S., Ueda S., Mori H., Seki M. Hemoglobin Aichi [α50 (CE8) HlsArg]: A new slightly unstable hemoglobin variant discovered in Japan. FEBS Letters 1984; 169: 297–299
  • Chih-Chuan L., Fei X., Kegong Y., Songsen C., Peichen J., Maoqi Z., Zhiheng Z. Hemoglobin GuiZhou or α2 77 (EF6) PROARG β2 a new slow-moving hemoglobin variant observed in China. Hemoglobin 1984; 8: 387–390
  • Zeng Y.-T., Huang S.-Z., Qiu X.-K., Cheng G.-C., Ren Z.-R., Jin Q.-C., Chen C.-Y., Jiao C.-T., Tang Z.-G., Liu R.-H., Bao X.-H., Zeng L.-Z., Duan Y.-Q., Zhang G.-Y. Hemoglobin Chongqing (α2 (N A2) LeuArg) and Hemoglobin Harbin (α16 (A14) LysMet) found in China. Hemoglobin 1984; 8: 569–581
  • Houjun L., Dexiang L., Zhiguo L., Ping L., Ly L., Ji C., Shaozhi H. A new fast-moving hemoglobin variant, Hb J-Tashikuergan α19 (AB1) AlaGlu. Hemoglobin 1984; 8: 391–395
  • Jones R. T., Shih F.-C., Head C. G., Koler R. D. Structural studies of electrophoretically silent hemoglobin variants by high performance liquid chromatography. Presented at the International Society Hematology Meeting, Argentina, September, 1984
  • Blouquit Y., Delanoe-Garin J., Lacombe C., Arous N., Cayre Y., Peduzzi J., Braconnier F., Galacteros F. Structural study of hemoglobin Hazebrouck, β38 (C4) ThrPro: A new abnormal hemoglobin with instability and low oxygen affinity (FEBS 1563). FEBS Letters 1984; 172: 155–158
  • Rahbar S., Asmerom Y., Blume K. G. A silent hemoglobin variant detected by HPLC: Hemoglobin City of Hope β69 (E13) GLYSER. Hemoglobin 1984; 8: 333–342
  • Williamson D., Brennan S. O., Strosberg H., Whitty J., Carell R. W. Hemoglobin A2 Fitzroy δ142 ALAASP: A new Delta-Chain variant. Hemoglobin 1984; 8: 325–332
  • Moo-Penn W. F., Johnson M. H., McGuffey J. E., Jue D. L. Hemoglobin Shelby [β131 (H9) CLNLYS]: A correction to the structure of Hemoglobin Deaconess and Hemoglobin Leslie. Hemoglobin 1984; 8: 583–593
  • Harano K., Harano T., Shibata S., Ueda S., Mori H., Saki M. Hb Okazaki [β93 (F8) CysArg], a new hemoglobin variant with increased oxygen affinity and instability. FEBS Letters 1984; 173: 45–47
  • Jeppsson J. O., Kallman L., Lindgren G., Fagerstam L. G. Hb Linkoping (β36 ProThr): a new hemoglobin mutant characterized by reversed-phase high performance liquid chromatography. J. Chromatog. 1984; 297: 31–36
  • Jones R. T., Barwick R. C., Head C. G., Shih F. C., Shih T. B. Hemoglobin Long Island. Abstract #151, 20th Congress of International Society of Haematology, Buenos AiresArgentina, 1984
  • Delano J., North M. L., Arous N., Bardakjian J., Pflumio F., Brunagel M. L., Lacombe C., Poyart C., Galacteros F., Rosa J., Blouquit Y. Hb Saverne: a new variant having an elongated β chain. Blood 1984; 64(Suppl. 1)56a
  • Wilson C. I. D., Cave R. J., Lehmann H., Close M., Imai K. Haemoglobin Warwickshire (β5 [A2] ProArg): A possible ‘fine tuning’ of 2,3-DPG affinity by β5 Pro (FEBS 1918). FEBS Letters 1984; 176: 331–333
  • Guis M., Mentzer W. C., Jue D. L., Johnson M. H., McGuffey J. E., Moo-Penn W. F. Hemoglobin Twin Peaks α113 (GH1) LeuHis. Hemoglobin 1985; 9: 175–177
  • Chen S. S., Webber B. B., Wilson J. B., Huisman T. H. J. Hb Gainesville-GA or α2β2 46 (CD5) GlyArg. Hemoglobin 1985; 9: 179–181
  • Delanoe-Garin J., Arous N., Blouquit Y., Hafsia R., Bardakdjian J., Lacombe C., Rosa J., Galacteros F. Hemoglobin Kenitra α2β2 69 (E13) GlyArg. A new β variant of elevated expression associated with α-thalassemia, found in a Moroccan woman. Hemoglobin 1985; 9: 1–9
  • Devaraj R., Wilson J. B., Huisman T. H. J. Hb Regina or α2β2 96 (FG3) LeuVal, a high oxygen affinity variant discovered by cation-exchange HPLC. Am. J. Hematol. 1985; 19: 195–200
  • Ohba Y., Imanaka M., Matsuoka M., Hattori Y., Miyaji T., Funaki C., Shibata K., Shimokata H., Kuzuya F., Miwa S. A new unstable, high oxygen affinity hemoglobin: Hb Nagoya or β97 (FG4) HisPro. Hemoglobin 1985; 9: 11–24
  • Wilson J. B., Webber B. B., Huisman T. H. J. Annotation: Hb Leslie is the same as Hb Shelby or α2β2 131 (H9) GlnLys. Hemogobin 1984; 8: 595–596
  • Chen S. S., Wilson J. B., Webber B.-B., Huisman T. H. J., Miwa S., Amenomori Y. Hb F-Tokyo or α2Gγ2 34 (B16) ValIle, a silent γ chain variant detected by reverse phase high performance liquid chromatography. Hemoglobin 1985; 9: 25–32
  • Chen S. S., Wilson J. B., Huisman T. H. J. Hb F-Pendergrass, and Aγ variant with a ProArg substitution at position γ36 (C2). Hemoglobin 1985; 9: 73–77
  • Al-Awamy B. H., Niazi G. A., Al-Mouzan M. I., Chen S. S., Wilton J. B., Webber B. B., Huisman T. H. J. Hb F-Damman or α2Aγ2 79 (EF3) AspAsn. Hemoglobin 1985; 9: 171–173
  • Blouquit Y., Lena-Russo D., Delanae I., Arous N., Bardakjian J., Lacombe C., Vovan L., Orsini A., Rosa J., Galacteros F. Hb Marsielle α2Aβ2 1 (Al) NH2-Met, 2 (A2) His 3 (A3) Pro: First variant having a N-terminal elongated β chain. Blood 1984; 64(Suppl. 1)55a
  • Shimasaki S. A new hemoglobin variant, Hemoglobin Nunobiki [α141 (HC3) ArgCys]. Notable influence of the carboxy-terminal cysteine upon various physico-chemical characteristics of hemoglobin. J. Clin. Invest. 1985; 75: 695–701
  • Adams J. G., III, Morrison W. T., Pullen D. J., Abney R. L., III, Steinberg M. H. Hemoglobin Mississippi (MS): a new hemoglobin variant with three distinct electrophoretic mobilities. Clin. Res. 1985; 33: 603A
  • Merault G., Keciard L., Saint-Martin C., Jasmin K., Campier A., Delanoe-Garin J., Arous N., Fortune R., Theodore M., Seytor S., Rosa J., Blouquit Y., Galacteros F. Hemoglobin Roseau-Pointe a Pitre α2β2 90 (F6) GluGly: a new hemoglobin variant with slight instability and low oxygen affinity. FEBS Lett. 1985; 184: 10–13
  • Como P. F., Hockey D., Trent R. J., Kronenberg H. (1985) Hb Geelong: β2 139 (H17) AsnAsp. A new hemoglobin with thalassemia-like characteristics. Presented as abstract at February meeting of N. S. W. Thalassemia Society. February, 1985
  • Barwick R. C., Jones R. T., Head C. G., Shih M. F.-C., Prchal J. T., Shih D. T.-B. Hb Long Island: A hemoglobin variant with a methionyl extension at the NH2 terminus and a prolyl substitution for the normal histidyl residue 2 Of the β chain. Proc. Natl. Acad. Sci., USA 1985; 82: 4602–4605
  • Blouquit Y., Arous N., Lena D., Delanoe-Garin J., Lacombe C., Bardakdjian J., Vovan L., Orsini A., Rosa J., Galacteros F. Hb Marseille [α2β2 N methionyl-2 (NA2) HisPro]: a new β chain variant having an extended N-terminus. FEES Lett. 1984; 178: 315–318
  • Shelton J. B., Shelton J. R., Schroeder W. A., Powars D. R. Hb Aztec or α276 (EF5) METTHRβ2 detection of a silent mutant by high performance liquid chromatography. Hemoglobin 1985; 9: 325–332
  • Harano T., Harano K., Ueda S. Hb Owari [α121 (H4) ValMet]: a new hemoglobin variant with a neutral-to-neutral amino acid substitution detected by isoelectric focusing. Hemoglobin 1986; 10, in press
  • Bowman J. E., Bloom R., Chen S.-S., Webber B. B., Wilson J. B., Kutlar A., Huisman T. H. J. Hb Chicago or α2136 (H19) LeuMet β2. Hemoglobin 1986, submitted
  • Rahbar S., Louis J., Lee T., Asmerom Y. Hemoglobin North Chicago (β36 [C2] ProlineSerine): A new high affinity hemoglobin. Hemoglobin 1985; 9: 559–576
  • Huisman T. H. J., Wilson J. B., Kutlar A., Yang K.-G., Chen S.-S., Webber B. B., Altay C., Martinez A. V. Hb J-Antakya or α2β2 65 (E9) LysMet in a Turkish family and Hb Complutense or α2β2 127 (H5) GlnGlu in a Spanish family; correction of a previously published identification. Biochim. Biophys. Acta 1986, submitted
  • Harano T., Harano K., Ueda S., Imai N., Kitazumi T. A new hemoglobin variant with a neutral to neutral amino acid substitution: Hemoglobin Kofu or α2β2 84 (EF8) ThrIIe. Hemoglobin 1986; 10, in press
  • Ohba Y., Miyaji T., Murakami M., Kadowaki S., Fujita T., Oimomi M., Hatanaka H., Ishikawa K., Baba S., Hitaka K., Imai K. Hb Himeji or β140 (H18) AlaAsp a slightly unstable hemoglobin with increased βN-terminal glycation. Hemoglobin 1986; 10, in press
  • Harano K., Harano T., Ueda S., Ohkushi T., Imai K. A new hemoglobin variant, Hb Mito [β144 (HC1) LysGlu], with increased oxygen affinity. FEBS Lett. 1985; 192: 75–78
  • Ohba Y., Igarashi M., Tsukahara M., Nakashima M., Sapada C., Ami M., Arai Y., Miyaji T. Hb A2 Yokoshima, α2δ2 25 (β7) GLYASP, a new δ chain variant found in a Japanese Family. Hemoglobin 1985; 9: 613–615
  • Fujita S., Ohta Y., Saito S., Kobayashi Y., Naritomi Y., Kawaguchi T., Imamura T., Wada Y., Hayashi A. Hemoglobin A2 Honai (α2δ290 (F6) Glu-Val): A new delta chain variant. Hemoglobin 1985; 9: 597–607
  • Hu H., Ma M. Hb F-Urumqi GγI 22 (B4) AspGly: a new fetal hemoglobin variant found in a Uygur baby. Hemoglobin 1986; 10, in press
  • Chen S.-S., Webber B. B., Kutlar A., Wilson J. B., Huisman T. H. J. Hb F-Cobb or α2Aγ2 37 (C3) TrpGly. Hemoglobin 1985; 9: 617–619
  • Chen S.-S., Wilson J. B., Webber B. B., Huisman T. H. J. Hb F-Beech Island or α2Aγ2 53 (D4) AlaAsp. Hemoglobin 1985; 9: 525–529
  • Boissel J.-P., Kasper T. J., Shah S. C., Malone J. I., Bunn H. F. Amino-terminal processing of proteins: Hemoglobin South Florida, a variant with retention of initiator methionine and Nα-acetylation. Proc. Natl. Acad. Sci., USA 1985; 82: 8448–8452
  • Barwick R. C., Head C. G., Shih M. F.-C., Block S. H., Jones R. T. Hb T-Cambodia [Beta 26 (B8) GluLys, Beta 121 (GH4) GluGln]: a new doubly substituted beta globin variant found in a Cambodian family. Blood 1985; 66(Suppl. 1)68a
  • Moo-Penn W. F., McGuffey J. E., Jue D. L., Johnson M. H., Schum T. Hemoglobin New Mexico: β100 (G2) ProArg. A variant hemoglobin associated with erythrocytosis (BBA 32356). Biochim. Biophys. Acta 1985; 832: 192–196

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.